[go: up one dir, main page]

CN110117237A - A kind of preparation method of aromatic nitriles or alkenyl nitrile compounds - Google Patents

A kind of preparation method of aromatic nitriles or alkenyl nitrile compounds Download PDF

Info

Publication number
CN110117237A
CN110117237A CN201810113897.7A CN201810113897A CN110117237A CN 110117237 A CN110117237 A CN 110117237A CN 201810113897 A CN201810113897 A CN 201810113897A CN 110117237 A CN110117237 A CN 110117237A
Authority
CN
China
Prior art keywords
ring
bis
solvent
formula
diphenylphosphino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201810113897.7A
Other languages
Chinese (zh)
Other versions
CN110117237B (en
Inventor
刘元红
甘易
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Institute of Organic Chemistry of CAS
Original Assignee
Shanghai Institute of Organic Chemistry of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Institute of Organic Chemistry of CAS filed Critical Shanghai Institute of Organic Chemistry of CAS
Priority to CN201810113897.7A priority Critical patent/CN110117237B/en
Publication of CN110117237A publication Critical patent/CN110117237A/en
Application granted granted Critical
Publication of CN110117237B publication Critical patent/CN110117237B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/16Preparation of carboxylic acid nitriles by reaction of cyanides with lactones or compounds containing hydroxy groups or etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/31Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/34Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring with cyano groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by unsaturated carbon chains
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/49Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/54Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84Nitriles
    • C07D213/85Nitriles in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyridine Compounds (AREA)

Abstract

本发明公开了一种芳香腈或烯基腈类化合物的制备方法。本发明的制备方法包括以下步骤:在惰性气体保护下,在溶剂中,在镍配合物、金属锌及添加剂存在的条件下,将如式II所示的芳基或杂芳基磺酸酯类化合物与氰基化试剂进行如下所示的交叉偶联反应,或将如IV所示的烯基磺酸酯类化合物与氰基化试剂进行如下所示的交叉偶联反应,即可;其中,所述的添加剂为4‑二甲氨基吡啶(DMAP),所述的氰基化试剂为氰化锌。本发明的制备方法可以以廉价的催化体系,简捷高效地实现芳基磺酸酯、杂芳基磺酸酯或烯基磺酸酯的氰基化,而且还具有良好的官能团兼容性和底物普适性,为实现芳香腈或烯基腈类化合物的工业合成提供了更好的应用前景和使用价值。 The invention discloses a preparation method of aromatic nitrile or alkenyl nitrile compound. The preparation method of the present invention comprises the following steps: under the protection of an inert gas, in a solvent, in the presence of nickel complexes, metal zinc and additives, the aryl or heteroaryl sulfonates shown in formula II The compound and the cyanation reagent carry out the cross-coupling reaction shown below, or carry out the cross-coupling reaction shown below with the alkenyl sulfonate compound shown in IV and the cyanation reagent; Wherein, The additive is 4-dimethylaminopyridine (DMAP), and the cyanation agent is zinc cyanide. The preparation method of the present invention can realize the cyanation of aryl sulfonate, heteroaryl sulfonate or alkenyl sulfonate simply and efficiently with a cheap catalytic system, and also has good functional group compatibility and substrate Universality provides better application prospect and use value for realizing the industrial synthesis of aromatic nitrile or alkenyl nitrile compounds.

Description

一种芳香腈或烯基腈类化合物的制备方法A kind of preparation method of aromatic nitrile or alkenyl nitrile compound

技术领域technical field

本发明涉及有机化学领域,具体涉及一种芳香腈或烯基腈类化合物的制备方法。The invention relates to the field of organic chemistry, in particular to a method for preparing aromatic nitrile or alkenyl nitrile compounds.

背景技术Background technique

作为有机化学中优良的反应中间体,芳香腈类化合物已经被广泛应用于生物学、医药、农药、功能材料等领域中。如2,4-二硝基-6-氰基苯胺是用于制造优良的亮蓝色重氮染料的重要中间体;4-溴-2,6-二氟苯甲腈是合成一种具有适中介电各向异性的优良液晶材料的重要合成中间体;同时很多天然产物和临床药物都含有氰基基团,如抗肿瘤药Letrozole、β抑制剂Bucindolol、激酶抑制剂Neratinib、心血管药cromakalim、抗HIV药Etravirine、抗痛风药Febuxostat、抗抑郁药Citalopram、糖尿病药物alogliptin等。氰基之所以广泛应用于药物化学研究中,这主要是由氰基的特殊性质所决定的。氰基具有相对较小的体积(约为甲基的1/8),此外氰基具有强吸电子性的特征,使得氰基成为一类良好的氢键受体,能够深入到靶标蛋白深处与活性部位的关键氨基酸残基形成强的氢键相互作用;同时,氰基极化度高,促进产生极性相互作用,因此药物分子中引入氰基可以改变药物分子的物理化学特性,增强药物分子与靶标蛋白的相互作用,从而提高药效;另外,氰基还具有良好的代谢稳定性以及作为羟基、羧基等官能团的生物电子排体,这些特点使得氰基成为药物化学研究中的一类非常重要的官能团。目前已大于30种的含氰基药物上市,多达20余种的含氰基药物正在研发中。As excellent reaction intermediates in organic chemistry, aromatic nitrile compounds have been widely used in biology, medicine, pesticides, functional materials and other fields. For example, 2,4-dinitro-6-cyanoaniline is an important intermediate for the manufacture of excellent bright blue diazo dyes; 4-bromo-2,6-difluorobenzonitrile is a synthetic compound with moderate An important synthetic intermediate of excellent liquid crystal materials with dielectric anisotropy; at the same time, many natural products and clinical drugs contain cyano groups, such as the antineoplastic drug Letrozole, the β inhibitor Bucindolol, the kinase inhibitor Neratinib, the cardiovascular drug cromakalim, Anti-HIV drug Etravirine, anti-gout drug Febuxostat, antidepressant Citalopram, diabetes drug alogliptin, etc. The reason why the cyano group is widely used in medicinal chemistry research is mainly determined by the special properties of the cyano group. The cyano group has a relatively small volume (about 1/8 of the methyl group), and in addition, the cyano group has strong electron-withdrawing characteristics, making the cyano group a good hydrogen bond acceptor, which can penetrate deep into the target protein It forms a strong hydrogen bond interaction with the key amino acid residues in the active site; at the same time, the cyano group has a high degree of polarization and promotes polar interactions, so the introduction of cyano groups into the drug molecule can change the physical and chemical properties of the drug molecule and enhance the drug. The interaction between the molecule and the target protein, thereby improving the efficacy of the drug; in addition, the cyano group also has good metabolic stability and serves as a bioelectron emitter of functional groups such as hydroxyl and carboxyl groups. These characteristics make the cyano group a class in medicinal chemistry research. Very important functional group. At present, more than 30 kinds of cyano-containing drugs have been listed, and as many as 20 kinds of cyano-containing drugs are under research and development.

芳香腈类化合物中的氰基还是一个重要的官能团,可以通过化学反应转换成其它官能团,形成其它重要的有机化合物,如:可以通过加氢还原得到酰胺类化合物;通过水解可以得到羧酸类化合物;通过还原可以得到伯胺类化合物或芳香醛类化合物;通过加成反应可以得到四氮唑类化合物;通过亲核加成可以得到羰基类化合物。The cyano group in aromatic nitrile compounds is also an important functional group, which can be converted into other functional groups through chemical reactions to form other important organic compounds, such as: amide compounds can be obtained by hydrogenation reduction; carboxylic acid compounds can be obtained by hydrolysis ; Primary amine compounds or aromatic aldehyde compounds can be obtained by reduction; tetrazole compounds can be obtained by addition reaction; carbonyl compounds can be obtained by nucleophilic addition.

鉴于氰基的独特性质和重要作用,含氰基的化合物特别是芳香腈类化合物的合成受到了人们的广泛关注。传统的合成芳香腈的方法是Rosenmund-von Braun反应和Sandmeyer反应,由于这两种方法都需要当量的氰化亚铜作为氰基化试剂,势必会造成重金属的污染,并且反应中通常需要较高的温度(150~250℃),后处理繁琐,从而限制了这两种方法的运用。工业上制备芳基腈化合物主要是通过氨氧化法,但其反应需要在高温高压下进行,并且使用大过量的氨,只局限于甲苯及其衍生物和甲基吡啶及其衍生物的氰基化反应,从而限制了该方法的运用。因此发展温和高效的氰基化方法,使之符合绿色化工的发展趋势,满足社会生产医药、材料等各相关领域迅速发展的需要,显得尤为迫切和需要。In view of the unique properties and important role of cyano group, the synthesis of cyano group-containing compounds, especially aromatic nitrile compounds, has attracted extensive attention. The traditional method of synthesizing aromatic nitriles is Rosenmund-von Braun reaction and Sandmeyer reaction, because these two kinds of methods all need the cuprous cyanide of equivalent as cyanation reagent, will certainly cause the pollution of heavy metal, and usually require higher The temperature (150 ~ 250 ℃), the post-processing is cumbersome, which limits the application of these two methods. The industrial preparation of aryl nitrile compounds is mainly through the ammoxidation method, but the reaction needs to be carried out under high temperature and pressure, and a large excess of ammonia is used, which is limited to the cyano group of toluene and its derivatives and picoline and its derivatives reaction, which limits the application of this method. Therefore, it is particularly urgent and necessary to develop a mild and efficient cyanation method to meet the development trend of green chemical industry and meet the rapid development of social production of medicine, materials and other related fields.

过渡金属催化的交叉偶联反应是构建碳碳键的有效的方法之一,利用过渡金属催化的亲电试剂与金属氰化物的交叉偶联反应可以有效地形成芳香腈类化合物。1973年Takagi课题组首次报道了钯催化的芳基碘化物或芳基溴化物同氰化钾的偶联反应(Takagi,K.;Okamoto,T.;Sakakiba,Y.;Oka,S.Chem.Lett.1973,471),虽然该论文中仅有局限的底物可以实现氰基化反应,但正是由于这种开创性的研究工作,在随后的几十年里,过渡金属催化的氰基化反应得到了广泛的研究和发展,一系列低毒的氰基化试剂被开发出来,如:TMSCN、Zn(CN)2、K4Fe(CN)6、丙酮氰醇、NCTS等。该类反应中芳基碘化物和芳基溴化物由于其较高的反应活性,经常被用作亲电试剂。来源相对广泛的芳基氯化合物由于C-Cl键键能高,活性较低,在早期的研究中很少被用作亲电试剂。但通过新型配体以及催化体系的发展,近年来芳基氯化物也逐渐被应用于金属催化的氰基化反应之中。然而,应用卤代烃为亲电试剂存在明显的不足:有机卤化物由于其自身毒性对环境有一定的危害;其次芳基卤化物进行偶联反应后会产生含卤素的副产物;并且芳基卤化物不太容易直接获得。因此,急需发展一些更加环保、绿色的亲电试剂来合成芳香腈类化合物。Transition metal-catalyzed cross-coupling reactions are one of the effective methods for constructing carbon-carbon bonds, and the cross-coupling reactions of transition metal-catalyzed electrophiles and metal cyanides can effectively form aromatic nitrile compounds. In 1973, the Takagi research group first reported the palladium-catalyzed coupling reaction of aryl iodide or aryl bromide with potassium cyanide (Takagi, K.; Okamoto, T.; Sakakiba, Y.; Oka, S. Chem. Lett.1973,471), although only limited substrates in this paper can achieve cyanation reaction, but it is precisely because of this pioneering research work that in the following decades, transition metal catalyzed cyano The cyanation reaction has been extensively researched and developed, and a series of low-toxic cyanation reagents have been developed, such as: TMSCN, Zn(CN) 2 , K 4 Fe(CN) 6 , acetone cyanohydrin, NCTS, etc. Aryl iodides and aryl bromides are often used as electrophiles in such reactions due to their high reactivity. Due to the high bond energy of C-Cl bond and low activity, aryl chloride compounds with relatively wide sources were rarely used as electrophiles in early research. However, through the development of new ligands and catalytic systems, aryl chlorides have gradually been applied in metal-catalyzed cyanation reactions in recent years. However, the application of halogenated hydrocarbons as electrophiles has obvious disadvantages: organic halides are harmful to the environment due to their own toxicity; secondly, aryl halides will produce halogen-containing by-products after coupling reactions; and aryl halides Halides are less readily available directly. Therefore, there is an urgent need to develop some more environmentally friendly and green electrophiles to synthesize aromatic nitriles.

通过文献调研,我们发现酚类化合物具有来源广泛、价格低廉、对环境友好等优点,逐渐被运用到交叉偶联反应中。同时,由于酚的C-O键断裂困难,将酚类化合物转化为酚类衍生物,可以实现底物的逐级官能团化。因此将酚类衍生物作为亲电试剂运用到偶联反应中具有重要的研究意义。近年来,利用过渡金属催化的酚类衍生物的氰基化反应报道仍然较少。1989年,Widdowson课题组首次报道了镍催化的三氟甲基磺酸芳基酯与氰化钾的偶联反应,合成了一系列的芳香腈类化合物。随后Percec小组进一步发展了镍催化的甲磺酸芳基酯与氰化钾的偶联反应。但是该反应中需要使用剧毒性的氰化钾作为氰基化试剂,另外当底物中邻位存在位阻时,反应收率较低,如当底物为2,4,6-三甲基苯基三氟甲磺酸酯为底物时,反应的收率为32%。(参考文献:Chambers,M.R.;Widdowson,D.A.J.Chem.Soc.Perkin trans.I 1989,1366;Percec,V.;Bae,J.Y.;Hill,D.H.J.Org.Chem.1995,60,6895.)。随后,Neumeyer小组和Fairfax小组报道了钯催化的三氟甲基磺酸芳基酯的氰基化反应,反应中采用毒性相对较低的氰化锌为氰源,但是反应中所需要的温度高达140℃-200℃。(参考文献:Zhang,A.;Neumeyer,J.L.Org.Lett.2003,5,201;Srivastava,R.R.;Zych,A.J.;Jenkins,D.M.;Wang,H.J.;Chen,Z.J.;Fairfax,D.J.Synthetic Communications,2007,37,431)。其后,Kwong课题组报道了以三水合的亚铁氰酸钾(K4[Fe(CN)6]·3H2O)为氰源,钯催化甲磺酸芳基酯或对甲苯磺酸芳基酯在温和条件下的偶联反应,反应中需要加入该小组开发的具有特殊的电子效应和位阻效应的吲哚类膦配体CM-phos,该配体结构特殊,并且价格比较昂贵。(参考文献Yeung,P.Y.;So,C.M.;Lau,C.P.;Kwong,F.Y.Angew.Chem.Int.Ed.2010,49,8918.)。2016年,Yamaguchi报道了以氨基乙腈为氰源,镍催化氨基甲酸芳基酯或芳基特戊酸酯的氰基化反应,反应需要使用大位阻富电性的dcype或dcypt为配体,并且反应所需温度高达150℃,从而限制了该反应的应用(参考文献:Takise,R.;Itami,K.;Yamaguchi,J.Org.Lett.2016,18,4428.)。鉴于上述过渡金属催化的酚类衍生物的氰基化反应都有其自身局限性,如需要特殊的膦配体,复杂的操作(预制备催化剂)及后处理,特殊的催化剂前体以及较高的反应温度和较长的反应时间等。Through literature research, we found that phenolic compounds have the advantages of wide sources, low price, and environmental friendliness, and have been gradually used in cross-coupling reactions. At the same time, due to the difficulty in cleavage of the CO bonds of phenols, the stepwise functionalization of substrates can be achieved by converting phenolic compounds into phenolic derivatives. Therefore, it is of great significance to use phenolic derivatives as electrophiles in coupling reactions. In recent years, there are still few reports on cyanation reactions of phenolic derivatives catalyzed by transition metals. In 1989, the Widdowson research group first reported the nickel-catalyzed coupling reaction of aryl trifluoromethanesulfonate and potassium cyanide, and synthesized a series of aromatic nitrile compounds. Subsequently, the Percec group further developed the nickel-catalyzed coupling reaction of aryl methanesulfonate with potassium cyanide. However, it is necessary to use highly toxic potassium cyanide as a cyanation reagent in this reaction. In addition, when there is steric hindrance in the ortho position of the substrate, the reaction yield is low, such as when the substrate is 2,4,6-trimethyl The yield of the reaction was 32% when phenyl triflate was used as substrate. (References: Chambers, MR; Widdowson, DAJ Chem. Soc. Perkin trans. I 1989, 1366; Percec, V.; Bae, JY; Hill, DHJ Org. Chem. 1995, 60, 6895.). Subsequently, the Neumeyer group and the Fairfax group reported the palladium-catalyzed cyanation reaction of aryl trifluoromethanesulfonate. In the reaction, zinc cyanide with relatively low toxicity was used as the cyanide source, but the temperature required for the reaction was as high as 140°C-200°C. (References: Zhang, A.; Neumeyer, JL Org. Lett. 2003, 5, 201; Srivastava, RR; Zych, AJ; Jenkins, DM; Wang, HJ; Chen, ZJ; Fairfax, DJ Synthetic Communications, 2007, 37, 431). Subsequently, the Kwong research group reported the use of potassium ferrocyanate trihydrate (K 4 [Fe(CN) 6 ]·3H 2 O) as the cyanide source, palladium-catalyzed aryl methanesulfonate or p-toluenesulfonate The coupling reaction of base esters under mild conditions requires the addition of the indole phosphine ligand CM-phos with special electronic effects and steric hindrance effects developed by the group. The ligand has a special structure and is relatively expensive. (References Yeung, PY; So, CM; Lau, CP; Kwong, FY Angew. Chem. Int. Ed. 2010, 49, 8918.). In 2016, Yamaguchi reported the cyanation reaction of aryl carbamate or aryl pivalate using aminoacetonitrile as the cyanide source and nickel catalyzed cyanation. The reaction requires the use of dcype or dcypt with large steric hindrance and electron-rich properties as ligands. And the temperature required for the reaction is as high as 150 °C, which limits the application of this reaction (References: Takise, R.; Itami, K.; Yamaguchi, J. Org. Lett. 2016, 18, 4428.). In view of the above-mentioned transition metal catalyzed cyanation reactions of phenolic derivatives have their own limitations, such as the need for special phosphine ligands, complex operations (pre-preparation of catalysts) and post-treatment, special catalyst precursors and higher reaction temperature and longer reaction time.

因此,探究和发展廉价的催化剂如镍和廉价的配体催化的更加高效、简捷、温和的磺酸酯类化合物的氰基化方法则显得十分迫切和需要,并且将为实现芳香腈或烯基腈类化合物的工业合成提供更好的应用前景。Therefore, it is very urgent and necessary to explore and develop a more efficient, simple and mild cyanation method of sulfonate compounds catalyzed by cheap catalysts such as nickel and cheap ligands, and it will be very urgent and necessary for the realization of aromatic nitrile or alkenyl The industrial synthesis of nitrile compounds provides better application prospects.

发明内容Contents of the invention

本发明所要解决的技术问题是为了克服现有的芳香腈或烯基腈类化合物的制备方法所使用的催化剂和配体价格昂贵、官能团兼容性差、底物普适性不好等不足,因而提供了一种芳香腈或烯基腈类化合物的制备方法。本发明的制备方法可以以廉价的催化体系,简捷高效地实现芳基磺酸酯、杂芳基磺酸酯或烯基磺酸酯的氰基化,而且还具有良好的官能团兼容性和底物普适性。The technical problem to be solved by the present invention is to overcome the shortcomings such as expensive catalysts and ligands used in the preparation methods of existing aromatic nitriles or alkenyl nitriles, poor functional group compatibility, poor substrate universality, etc., thus providing A preparation method of aromatic nitrile or alkenyl nitrile compound is provided. The preparation method of the present invention can realize the cyanation of aryl sulfonate, heteroaryl sulfonate or alkenyl sulfonate simply and efficiently with a cheap catalytic system, and also has good functional group compatibility and substrate universality.

本发明是通过下述技术方案来解决上述技术问题的。The present invention solves the above-mentioned technical problems through the following technical solutions.

本发明提供了一种如式I所示的芳香腈类化合物的制备方法,其包括以下步骤:在惰性气体保护下,在溶剂中,在镍配合物、金属锌及添加剂存在的条件下,将如式II所示的芳基或杂芳基磺酸酯类化合物与氰基化试剂进行如下所示的交叉偶联反应,即可;其中,所述的添加剂为4-二甲氨基吡啶(DMAP),所述的氰基化试剂为氰化锌;The present invention provides a kind of preparation method of the aromatic nitrile compound shown in formula I, it comprises the following steps: under inert gas protection, in solvent, under the condition that nickel complex, metal zinc and additive exist, will The aryl or heteroaryl sulfonate compound shown in formula II and the cyanation reagent carry out the cross-coupling reaction as shown below; wherein, the additive is 4-dimethylaminopyridine (DMAP ), the cyanation reagent is zinc cyanide;

在如式I所示的芳香腈类化合物和如式II所示的芳基或杂芳基磺酸酯类化合物中,In the aromatic nitrile compound shown in formula I and the aryl or heteroaryl sulfonate compound shown in formula II,

n选自0-[M-1]之间的任一整数,其中M表示环α上的最大取代个数,例如n可为0、1或2。n is selected from any integer between 0-[M-1], wherein M represents the maximum number of substitutions on ring α, for example, n can be 0, 1 or 2.

R1可相同或不同,其各自独立地选自卤素、C1-C6的直链或支链烷氧基、-CN、-C(=O)ORa、-NRbRc、-C(=O)Rd、-C(=O)NReRf、Rg取代的C3-C10的芳基或杂芳基、Rh取代的C1-C6的直链或支链烷基;其中,Ra、Rb、Rc、Rd、Re、Rf、Rg和Rh各自独立地选自-H、卤素、-OH、-CN、C1-C4的直链或支链烷氧基和C1-C4的直链或支链烷基中的一种或多种;其中,所述的卤素优选为氟、氯、溴或碘;所述的C1-C4的直链或支链烷氧基优选C1-C3的直链或支链烷氧基,进一步优选为甲氧基、乙氧基、丙氧基或异丙氧基;所述的C1-C4的直链或支链烷基优选为C1-C3的直链或支链烷基,进一步优选为甲基、乙基、丙基或异丙基。R 1 may be the same or different, each independently selected from halogen, C 1 -C 6 linear or branched alkoxy, -CN, -C(=O)OR a , -NR b R c , -C (=O)R d , -C(=O)NR e R f , C 3 -C 10 aryl or heteroaryl substituted by R g , straight or branched C 1 -C 6 substituted by Rh Alkyl; wherein, R a , R b , R c , R d , Re , R f , R g and R h are each independently selected from -H, halogen, -OH, -CN, C 1 -C 4 One or more of linear or branched alkoxy and C 1 -C 4 linear or branched alkyl; wherein, the halogen is preferably fluorine, chlorine, bromine or iodine; the C 1 - C4 linear or branched alkoxy is preferably C1 - C3 linear or branched alkoxy, more preferably methoxy, ethoxy, propoxy or isopropoxy; The above C 1 -C 4 linear or branched alkyl is preferably a C 1 -C 3 linear or branched alkyl, more preferably methyl, ethyl, propyl or isopropyl.

或者,任意两个相邻取代的所述R1(当n>=2时)与其各自相连的环α上的原子共同构成一个与环α并环的碳环或碳杂环,所述的碳环或碳杂环为3-10元环,所述的碳杂环含有1-4个选自O、N和S的杂原子。Alternatively, any two adjacently substituted R 1 (when n>=2) and the atoms on the ring α connected to each other together form a carbocyclic or carbon heterocyclic ring parallel to the ring α, and the carbon The ring or carboheterocycle is a 3-10 membered ring, and said carboheterocycle contains 1-4 heteroatoms selected from O, N and S.

当R1为卤素时,所述的卤素优选为氟、氯、溴或碘。When R 1 is halogen, said halogen is preferably fluorine, chlorine, bromine or iodine.

当R1为C1-C6的直链或支链烷氧基时,所述的C1-C6的直链或支链烷氧基优选为C1-C3的直链或支链烷氧基,进一步优选为甲氧基、乙氧基、丙氧基或异丙氧基。When R 1 is a C 1 -C 6 linear or branched alkoxy group, the C 1 -C 6 linear or branched alkoxy group is preferably a C 1 -C 3 linear or branched chain The alkoxy group is more preferably methoxy, ethoxy, propoxy or isopropoxy.

当R1为-C(=O)ORa时,Ra优选为C1-C4的直链或支链烷基,进一步优选为甲基、乙基、丙基或异丙基。When R 1 is -C(=O)OR a , R a is preferably a C 1 -C 4 linear or branched chain alkyl group, more preferably methyl, ethyl, propyl or isopropyl.

当R1为-NRbRc时,Rb和Rc各自独立地优选为C1-C4的直链或支链烷基,进一步优选为甲基、乙基、丙基或异丙基。When R 1 is -NR b R c , R b and R c are each independently preferably C 1 -C 4 linear or branched chain alkyl, more preferably methyl, ethyl, propyl or isopropyl .

当R1为-C(=O)Rd时,Rd优选为C1-C4的直链或支链烷基,进一步优选为甲基、乙基、丙基或异丙基。When R 1 is -C(=O)R d , R d is preferably a C 1 -C 4 linear or branched chain alkyl group, more preferably methyl, ethyl, propyl or isopropyl.

当R1为-C(=O)NReRf时,Re和Rf各自独立地优选为C1-C4的直链或支链烷基,进一步优选为甲基、乙基、丙基或异丙基。When R 1 is -C(=O)NR e R f , R e and R f are each independently preferably C 1 -C 4 linear or branched chain alkyl, more preferably methyl, ethyl, propylene base or isopropyl.

当R1为Rg取代的C3-C10的芳基或杂芳基时,所述的C3-C10的芳基或杂芳基优选为苯基或噻吩基;When R 1 is a C 3 -C 10 aryl or heteroaryl group substituted by R g , the C 3 -C 10 aryl or heteroaryl group is preferably phenyl or thienyl;

当R1为Rh取代的C1-C6的直链或支链烷基时,所述的C1-C6的直链或支链烷基优选为C1-C3的直链或支链烷基,进一步优选为甲基、乙基、丙基或异丙基。When R 1 is a C 1 -C 6 straight chain or branched chain alkyl substituted by Rh , the C 1 -C 6 straight chain or branched chain alkyl is preferably a C 1 -C 3 straight chain or The branched alkyl group is more preferably methyl, ethyl, propyl or isopropyl.

当任意两个相邻取代的所述R1(当n>=2时)与其各自相连的环α上的原子共同构成一个与环α并环的碳环或碳杂环,所述的碳环或碳杂环优选为3-5元环,所述的碳杂环含有1或2个选自O、N和S的杂原子。When any two adjacently substituted R 1 (when n>=2) and the atoms on the ring α connected to each other form a carbocyclic or carbon heterocyclic ring combined with the ring α, the carbocyclic ring Or the carboheterocycle is preferably a 3-5 membered ring, and the carboheterocycle contains 1 or 2 heteroatoms selected from O, N and S.

当n为1时,R1进一步优选选自甲基、正丁基、甲氧基、氨基、乙酰基、甲氧基羰基、乙氧基羰基、氰基和苯基。When n is 1 , R is further preferably selected from methyl, n-butyl, methoxy, amino, acetyl, methoxycarbonyl, ethoxycarbonyl, cyano and phenyl.

当n为2时,R1可相同或不同,其进一步各自独立地优选选自甲基或甲氧基;或两个R1与其各自相连的环α上的原子共同构成二氧杂环戊基。When n is 2, R 1 can be the same or different, which are further independently preferably selected from methyl or methoxy; or two R 1 and the atoms on the ring α to which they are respectively connected together form a dioxolyl group .

-OS(=O)2R为本领域常规所述可作为良好的离去基团的磺酸酯结构,其中R选自卤素、C1-C6的直链或支链烷基、C1-C6的直链或支链卤代烷基、或Ri取代的苯基,Ri选自卤素(如氟、氯、溴或碘)、C1-C6的直链或支链烷基(优选C1-C3的直链或支链烷基,进一步优选为甲基、乙基、丙基或异丙基)、或-NRjRk(Rj和Rk各自独立地选自C1-C4的直链或支链烷基,进一步优选为甲基、乙基、丙基或异丙基)。-OS(=O) 2 R is a sulfonate ester structure that can be used as a good leaving group conventionally described in the art, wherein R is selected from halogen, C 1 -C 6 linear or branched chain alkyl, C 1 -C 6 straight chain or branched chain haloalkyl, or R i substituted phenyl, R i selected from halogen (such as fluorine, chlorine, bromine or iodine), C 1 -C 6 straight chain or branched chain alkyl ( Preferably C 1 -C 3 linear or branched chain alkyl, more preferably methyl, ethyl, propyl or isopropyl), or -NR j R k (R j and R k are each independently selected from C 1 - C4 straight or branched chain alkyl, more preferably methyl, ethyl, propyl or isopropyl).

当R为卤素时,所述的卤素优选为氟、氯、溴或碘。When R is halogen, said halogen is preferably fluorine, chlorine, bromine or iodine.

当R为C1-C6的直链或支链烷基时,所述的C1-C6的直链或支链烷基优选C1-C3的直链或支链烷基,进一步优选为甲基、乙基、丙基或异丙基。When R is a C 1 -C 6 straight chain or branched chain alkyl group, the C 1 -C 6 straight chain or branched chain alkyl group is preferably a C 1 -C 3 straight chain or branched chain alkyl group, further Preferred is methyl, ethyl, propyl or isopropyl.

当R为C1-C6的直链或支链卤代烷基时,所述的C1-C6的直链或支链卤代烷基优选为C1-C3的直链或支链卤代烷基,进一步优选为三氟甲基。When R is a C 1 -C 6 straight chain or branched chain haloalkyl, said C 1 -C 6 straight chain or branched chain haloalkyl is preferably a C 1 -C 3 straight chain or branched chain haloalkyl, More preferred is trifluoromethyl.

本发明中,所述的-OS(=O)2R优选为以下任一结构:氟磺酰基(-SO2F)、三氟甲磺酰基(-Tf)、甲磺酰基(-Ms)、对甲苯基磺酰基(-Ts)或氨基磺酰基(-SO2NMe2)。In the present invention, the -OS(=O) 2 R is preferably any of the following structures: fluorosulfonyl (-SO 2 F), trifluoromethanesulfonyl (-Tf), methylsulfonyl (-Ms), p-tolylsulfonyl (-Ts) or aminosulfonyl (-SO 2 NMe 2 ).

本发明中,在如式I所示的芳香腈类化合物和如式II所示的芳基或杂芳基磺酸酯类化合物中,所述的环α为芳环或芳杂环。In the present invention, in the aromatic nitrile compound shown in formula I and the aryl or heteroaryl sulfonate compound shown in formula II, the ring α is an aromatic ring or an aromatic heterocyclic ring.

其中,当所述的环α为芳环时,所述的芳环是指任何稳定的在各环中可高达6个原子的单环或多环碳环,所述的多环可为二环、三环或四环的并环结构,且其中至少一个环是芳香环;当所述的芳环为多环且其中存在非芳香环时,-OS(=O)2R和-CN与其的连接是分别通过“芳香环”进行的;而n个相同或不同的R1与其的连接并不进行任何限定。Wherein, when the ring α is an aromatic ring, the aromatic ring refers to any stable monocyclic or polycyclic carbocyclic ring with up to 6 atoms in each ring, and the polycyclic ring can be bicyclic , a tricyclic or tetracyclic ring structure, and at least one of the rings is an aromatic ring; when the aromatic ring is polycyclic and there are non-aromatic rings, -OS(=O) 2 R and -CN and their The connection is carried out respectively through the "aromatic ring"; and the connection of n identical or different R 1s to it is not limited in any way.

其中,当所述的环α为芳杂环时,所述的芳杂环是指任何稳定的各环中可高达6个原子的稳定单环或者多环,所述的多环可为二环、三环或四环的并环结构,且其中至少一个环是芳香环并且含有1-4个选自O、N和S的杂原子。当所述的芳杂环为多环且其中存在非芳香环或者不包含杂原子时,-OS(=O)2R和-CN与其的连接分别是通过“含有杂原子的芳香环”进行的;而n个相同或不同的-R1与其的连接并不进行任何限定。Wherein, when the ring α is an aromatic heterocycle, the aromatic heterocycle refers to any stable monocyclic or polycyclic ring with up to 6 atoms in each ring, and the polycyclic ring can be bicyclic , a tricyclic or tetracyclic ring structure, wherein at least one ring is an aromatic ring and contains 1-4 heteroatoms selected from O, N and S. When the aromatic heterocyclic ring is polycyclic and there is a non-aromatic ring or does not contain heteroatoms, the connections of -OS(=O) 2 R and -CN to it are respectively carried out through "aromatic rings containing heteroatoms"; and the connection of n identical or different -R 1s to them is not limited.

本发明中,所述的芳环优选为单环类芳香环或二环类稠环芳香环,例如苯环或萘环。In the present invention, the aromatic ring is preferably a monocyclic aromatic ring or a bicyclic condensed aromatic ring, such as a benzene ring or a naphthalene ring.

本发明中,所述的芳杂环优选为单环类吡啶环或双环类喹啉环。In the present invention, the aromatic heterocycle is preferably a monocyclic pyridine-like ring or a bicyclic quinoline-like ring.

本发明中,所述的如式II所示的芳基或杂芳基磺酸酯类化合物和如式I所示的芳香腈类化合物进一步优选为如下任意一对化合物:In the present invention, the aryl or heteroaryl sulfonate compound shown in formula II and the aromatic nitrile compound shown in formula I are further preferably any pair of compounds as follows:

所述的如式I所示的芳香腈类化合物的制备方法中,所述的交叉偶联反应在惰性气体保护体系下进行,所述的惰性保护气体可为氮气、氦气、氩气和氖气中的一种或多种。In the preparation method of the described aromatic nitrile compound shown in formula I, described cross-coupling reaction is carried out under inert gas protection system, and described inert protection gas can be nitrogen, helium, argon and neon One or more of the air.

所述的如式I所示的芳香腈类化合物的制备方法中,所述的添加剂DMAP的用量可为本领域常规所用;本发明优选所述的如式II所示的芳基或杂芳基磺酸酯类化合物与DMAP的摩尔比为1:0.1-1:10,更优选为1:1-1:1.5。In the described preparation method of the aromatic nitrile compound shown in formula I, the consumption of described additive DMAP can be routinely used in the art; The present invention preferably described aryl or heteroaryl group shown in formula II The molar ratio of sulfonate compound to DMAP is 1:0.1-1:10, more preferably 1:1-1:1.5.

所述的如式I所示的芳香腈类化合物的制备方法中,除所述的添加剂DMAP外,还可加入其他添加剂,所述的其他添加剂为季铵盐和/或无机盐;其中,所述的季铵盐优选四乙基碘化铵;所述的无机盐优选碘化钠、碘化钾和碘化锂中一种或多种,更优选碘化钾。In the described preparation method of the aromatic nitrile compound shown in formula I, except described additive DMAP, also can add other additive, described other additive is quaternary ammonium salt and/or inorganic salt; Wherein, all The quaternary ammonium salt is preferably tetraethylammonium iodide; the inorganic salt is preferably one or more of sodium iodide, potassium iodide and lithium iodide, more preferably potassium iodide.

所述的如式I所示的芳香腈类化合物的制备方法中,当所述反应体系中还包含季铵盐和/或无机盐时,所述的季铵盐和/或无机盐的用量可为本领域常规所用;本发明优选所述的如式II所示的芳基或杂芳基磺酸酯类化合物与所述的季铵盐和/或无机盐的摩尔比为1:0.1-1:10,更优选为1:0.5-1:1。In the described preparation method of the aromatic nitrile compound shown in formula I, when also comprising quaternary ammonium salt and/or inorganic salt in described reaction system, the consumption of described quaternary ammonium salt and/or inorganic salt can be It is routinely used in the art; the molar ratio of the preferred aryl or heteroaryl sulfonate compound shown in formula II and the quaternary ammonium salt and/or inorganic salt in the present invention is 1:0.1-1 :10, more preferably 1:0.5-1:1.

所述的如式I所示的芳香腈类化合物的制备方法中,所述的金属锌的用量可为本领域此类反应常规所用;本发明优选所述的如式II所示的芳基或杂芳基磺酸酯类化合物与所述的金属锌的摩尔比为1:0.01-1:10,更优选为1:0.1-1:1,进一步优选为1:0.2-1:0.4。In the described preparation method of the aromatic nitrile compound shown in formula I, the consumption of described metal zinc can be this type of reaction conventional use in this area; The present invention preferably described aryl group shown in formula II or The molar ratio of the heteroaryl sulfonate compound to the metal zinc is 1:0.01-1:10, more preferably 1:0.1-1:1, further preferably 1:0.2-1:0.4.

所述的如式I所示的芳香腈类化合物的制备方法中,所述的镍配合物可为本领域该类交叉偶联反应常规所用,其可以已制备得到的本领域熟知的常规适用的镍前体催化剂与其常规适用配体的金属配合物形式参与反应,此时亦可不再另加其他配体;也可以将本领域熟知的常规适用的镍前体催化剂与其常规适用配体在反应体系中进行原位配位后再参与反应。本发明优选所述的镍配合物为NiBr2(PPh3)2和/或NiCl2(dppf);或,本发明优选所述的镍前体催化剂选自Ni(cod)2、NiCl2、NiBr2、NiI2、NiBr2(diglyme)、NiCl2(glyme)、NiBr2(DME)、NiF2和NiCl2·6H2O中的一种或多种;例如NiBr2(DME)、NiI2和NiCl2·6H2O中的一种或多种。In the preparation method of the aromatic nitrile compound shown in the described formula I, the nickel complex can be conventionally used in this type of cross-coupling reaction in the art, and it can be prepared by a conventionally applicable compound well known in the art. The metal complex form of the nickel precursor catalyst and its conventionally applicable ligand participates in the reaction, and at this time, no other ligands can be added; the conventionally applicable nickel precursor catalyst well known in the art and its conventionally applicable ligand can also be used in the reaction system Participate in the reaction after in situ coordination. The preferred nickel complex of the present invention is NiBr 2 (PPh 3 ) 2 and/or NiCl 2 (dppf); or, the preferred nickel precursor catalyst of the present invention is selected from Ni(cod) 2 , NiCl 2 , NiBr 2 , one or more of NiI 2 , NiBr 2 (diglyme), NiCl 2 (glyme), NiBr 2 (DME), NiF 2 and NiCl 2 ·6H 2 O; for example NiBr 2 (DME), NiI 2 and One or more of NiCl 2 ·6H 2 O.

所述的如式I所示的芳香腈类化合物的制备方法中,所述的镍配合物的用量可为本领域该类反应常规所用;本发明优选所述的如式II所示的芳基或杂芳基磺酸酯类化合物与所述的镍配合物的摩尔比为1:0.01-1:1,更优选1:0.02-1:0.50,进一步优选1:0.05-1:0.10。In the described preparation method of the aromatic nitrile compound shown in formula I, the consumption of described nickel complex can be this kind of reaction conventional use in this area; The present invention preferably described aryl group shown in formula II Or the molar ratio of the heteroaryl sulfonate compound to the nickel complex is 1:0.01-1:1, more preferably 1:0.02-1:0.50, further preferably 1:0.05-1:0.10.

所述的如式I所示的芳香腈类化合物的制备方法中,如所述反应体系中还包含所述的常规适用配体,其可为本领域该类交叉偶联反应中适用于镍催化剂的常规配体,可选自三苯基膦(PPh3)、三乙基膦、三丁基膦(TBUP)、三环己基膦(TCHP)、双二苯基膦甲烷(dppm)、二甲基苯基膦(PMe2Ph)、二苯基甲基膦(PMePh2)、1,2-双(二苯膦)乙烷(dppe)、1,3-双(二苯基膦)丙烷(dppp)、1,4-双(二苯基膦)丁烷(dppb)、1,1'-双(二苯基膦)二茂铁(dppf)、9,9-二甲基-4,5-双二苯基膦氧杂蒽(xantphos)、4,5-二(二叔丁基膦)-9,9-二甲基氧杂蒽(tBu-xantphos)和3-(二环己基膦基)-1-甲基-2-苯基-1H-吲哚(CM-phos)中的一种或多种,更优选双二苯基膦甲烷(dppm)、二苯基甲基膦(PMePh2)、1,2-双(二苯膦)乙烷(dppe)、1,3-双(二苯基膦)丙烷(dppp)、1,4-双(二苯基膦)丁烷(dppb)、1,1'-双(二苯基膦)二茂铁(dppf)和9,9-二甲基-4,5-双二苯基膦氧杂蒽(xantphos)中的一种或多种;例如二苯基甲基膦、1,1'-双(二苯基膦)二茂铁和9,9-二甲基-4,5-双二苯基膦氧杂蒽中的一种或多种。In the described preparation method of the aromatic nitrile compound shown in formula I, if also comprise described conventional suitable part in described reaction system, it can be suitable for nickel catalyst in this kind of cross-coupling reaction in this field The conventional ligands can be selected from triphenylphosphine (PPh 3 ), triethylphosphine, tributylphosphine (TBUP), tricyclohexylphosphine (TCHP), bisdiphenylphosphine methane (dppm), dimethyl phenylphosphine (PMe 2 Ph), diphenylmethylphosphine (PMePh 2 ), 1,2-bis(diphenylphosphine)ethane (dppe), 1,3-bis(diphenylphosphine)propane ( dppp), 1,4-bis(diphenylphosphino)butane (dppb), 1,1'-bis(diphenylphosphino)ferrocene (dppf), 9,9-dimethyl-4,5 -bis-diphenylphosphine-xanthene ( xantphos ), 4,5-bis(di-tert-butylphosphine)-9,9-dimethylxanthene (tBu-xantphos) and 3-(dicyclohexylphosphine One or more of -1-methyl-2-phenyl-1H-indole (CM-phos), more preferably bisdiphenylphosphine methane (dppm), diphenylmethylphosphine (PMePh 2 ), 1,2-bis(diphenylphosphine)ethane (dppe), 1,3-bis(diphenylphosphine)propane (dppp), 1,4-bis(diphenylphosphine)butane (dppb ), 1,1'-bis(diphenylphosphino)ferrocene (dppf) and 9,9-dimethyl-4,5-bisdiphenylphosphoxanthene (xantphos) species; for example one of diphenylmethylphosphine, 1,1'-bis(diphenylphosphino)ferrocene and 9,9-dimethyl-4,5-bisdiphenylphosphoxanthene or more.

所述的如式I所示的芳香腈类化合物的制备方法中,如所述反应体系中还包含所述的常规适用配体,所述的镍前体催化剂与所述的配体的摩尔比可为本领域该类交叉偶联反应常规所用。本发明优选摩尔比为1:1~1:10,更优选1:1~1:5,进一步优选1:1.2。In the described preparation method of the aromatic nitrile compound shown in formula I, also comprise described conventional applicable ligand in described reaction system, the molar ratio of described nickel precursor catalyst and described ligand It can be used routinely in this type of cross-coupling reaction in the art. In the present invention, the preferred molar ratio is 1:1 to 1:10, more preferably 1:1 to 1:5, and even more preferably 1:1.2.

所述的如式I所示的芳香腈类化合物的制备方法中,所述的如式II所示的芳基或杂芳基磺酸酯类化合物与所述的氰基化试剂的摩尔比可为本领域该类反应常规的摩尔比;本发明优选1:0.1-1:10,更优选1:0.5-1:2,进一步优选1:0.6-1:1.2,例如1:0.8。In the preparation method of described aromatic nitrile compound shown in formula I, the mol ratio of described aryl or heteroaryl sulfonate compound shown in formula II and described cyanation reagent can be It is a conventional molar ratio for this type of reaction in the art; in the present invention, it is preferably 1:0.1-1:10, more preferably 1:0.5-1:2, further preferably 1:0.6-1:1.2, for example 1:0.8.

所述的如式I所示的芳香腈类化合物的制备方法中,所述的溶剂可为本领域该类交叉偶联反应常规所用,不参与反应即可;本发明优选芳烃类溶剂、醚类溶剂、卤代烃类溶剂、腈类溶剂、酰胺类溶剂和亚砜类溶剂中的一种或多种;所述的芳烃类溶剂优选苯、甲苯和二甲苯中的一种或多种;所述的醚类溶剂优选乙醚、1,4-二氧六环和四氢呋喃中的一种或多种;所述的卤代烃类溶剂优选氯代烃类溶剂;所述的氯代烃类溶剂优选二氯甲烷、二氯乙烷和氯仿中的一种或多种;所述的腈类溶剂优选乙腈;所述的酰胺类溶剂优选N,N-二甲基甲酰胺、N,N-二甲基乙酰胺(DMA)和六甲基磷酰胺中的一种或多种;所述的亚砜类溶剂优选二甲基亚砜。所述的溶剂更优选乙腈、N,N-二甲基甲酰胺和N,N-二甲基乙酰胺中的一种或多种。In the described preparation method of the aromatic nitrile compound shown in formula I, described solvent can be this type of cross-coupling reaction conventional use in this area, does not participate in reaction and gets final product; The present invention preferably aromatic hydrocarbon solvent, ethers One or more of solvents, halogenated hydrocarbon solvents, nitrile solvents, amide solvents and sulfoxide solvents; the aromatic hydrocarbon solvent is preferably one or more of benzene, toluene and xylene; the One or more of said ether solvent is preferably ether, 1,4-dioxane and tetrahydrofuran; said halogenated hydrocarbon solvent is preferably chlorinated hydrocarbon solvent; said chlorinated hydrocarbon solvent is preferably One or more of dichloromethane, dichloroethane and chloroform; the preferred acetonitrile of the described nitrile solvent; the preferred N,N-dimethylformamide, N,N-dimethylformamide of the described amide solvent One or more of methyl acetamide (DMA) and hexamethylphosphoramide; the sulfoxide solvent is preferably dimethyl sulfoxide. The solvent is more preferably one or more of acetonitrile, N,N-dimethylformamide and N,N-dimethylacetamide.

所述的如式I所示的芳香腈类化合物的制备方法中,所述的溶剂的用量可为本领域该类交叉偶联反应常规所用;本发明优选所述的如式II所示的芳基或杂芳基磺酸酯类化合物与所述的溶剂的摩尔体积比为0.01mmol/mL-1mmol/mL,更优选0.1mmol/mL-0.5mmol/mL。In the described preparation method of the aromatic nitrile compound shown in formula I, the consumption of described solvent can be the conventional use of this type of cross-coupling reaction in this area; The preferred described aromatic nitrile compound shown in formula II of the present invention The molar volume ratio of the base or heteroaryl sulfonate compound to the solvent is 0.01mmol/mL-1mmol/mL, more preferably 0.1mmol/mL-0.5mmol/mL.

所述的如式I所示的芳香腈类化合物的制备方法中,所述的交叉偶联反应的反应温度可为本领域该类交叉偶联反应常规所用;本发明中可为-100℃-500℃,优选0℃-150℃,更优选50℃-100℃,进一步优选60℃-80℃。In the preparation method of the aromatic nitrile compound as shown in formula I, the reaction temperature of the cross-coupling reaction can be conventionally used in this type of cross-coupling reaction in the art; in the present invention, it can be -100°C- 500°C, preferably 0°C-150°C, more preferably 50°C-100°C, further preferably 60°C-80°C.

所述的如式I所示的芳香腈类化合物的制备方法中,所述的交叉偶联反应的反应进程可以采用本领域中该类交叉偶联反应所用的常规监测方法(例如TLC、HPLC或NMR)进行监测,一般以所述的如式II所示的芳基或杂芳基磺酸酯类化合物消失或不再反应时为反应终点。In the described preparation method of the aromatic nitrile compound shown in formula I, the reaction process of described cross-coupling reaction can adopt the conventional monitoring method (such as TLC, HPLC or NMR) is monitored, generally with the described aryl or heteroaryl sulfonate compounds as shown in formula II disappearing or no longer reacting as the reaction end point.

所述的如式I所示的芳香腈类化合物的制备方法中,所述的交叉偶联反应的反应时间可为本领域该类交叉偶联反应常规所用;本发明中优选0.1-200h,进一步优选3-12h。In the preparation method of the aromatic nitrile compound shown in the described formula I, the reaction time of the cross-coupling reaction can be conventionally used in this type of cross-coupling reaction in the art; preferably 0.1-200h in the present invention, further Preferably 3-12h.

所述的如式I所示的芳香腈类化合物的制备方法中,所述的制备方法在所述的交叉偶联反应结束后,优选还可包括以下后处理步骤:反应结束后,过滤,除去溶剂,柱色谱分离得到目标化合物,所述的柱色谱分离可以采用本领域中该类操作的常规方法。洗脱剂优选烷烃类溶剂与酯类溶剂的混合溶剂。其中,所述的烷烃类溶剂与所述的酯类溶剂的体积比优选100:1-1:1;所述的烷烃类溶剂优选石油醚;所述的酯类溶剂优选乙酸乙酯。In the preparation method of the described aromatic nitrile compound shown in formula I, after the described cross-coupling reaction finishes, the described preparation method can also preferably include the following post-processing steps: after the reaction finishes, filter, remove Solvent, column chromatographic separation to obtain the target compound, and the column chromatographic separation can adopt conventional methods of this type of operation in the art. The eluent is preferably a mixed solvent of an alkane solvent and an ester solvent. Wherein, the volume ratio of the alkane solvent to the ester solvent is preferably 100:1-1:1; the alkane solvent is preferably petroleum ether; the ester solvent is preferably ethyl acetate.

本发明还提供了一种如式III所示的烯基腈类化合物的制备方法,其包括以下步骤:在惰性气体保护下,在溶剂中,在镍配合物、金属锌及添加剂存在的条件下,将如IV所示的烯基磺酸酯类化合物与氰基化试剂进行如下所示的交叉偶联反应,即可;其中,所述的添加剂为4-二甲氨基吡啶(DMAP);所述的氰基化试剂为氰化锌;The present invention also provides a method for preparing an alkenyl nitrile compound as shown in formula III, which comprises the following steps: under the protection of an inert gas, in a solvent, in the presence of nickel complexes, metal zinc and additives , carrying out the following cross-coupling reaction with the alkenyl sulfonate compound shown in IV and the cyanation reagent; wherein, the additive is 4-dimethylaminopyridine (DMAP); the Described cyanation reagent is zinc cyanide;

其中,-OS(=O)2R为本领域常规所述可作为良好的离去基团的磺酸酯结构,其定义同前所述,即:R选自卤素、C1-C6的直链或支链烷基、C1-C6的直链或支链卤代烷基、或Ri取代的苯基,Ri选自卤素(如氟、氯、溴或碘)、C1-C6的直链或支链烷基(优选C1-C3的直链或支链烷基,进一步优选为甲基、乙基、丙基或异丙基)、或-NRjRk(Rj和Rk各自独立地选自C1-C4的直链或支链烷基,进一步优选为甲基、乙基、丙基或异丙基)。Among them, -OS(=O) 2 R is a sulfonate structure that can be used as a good leaving group conventionally described in the art, and its definition is the same as mentioned above, that is: R is selected from halogen, C 1 -C 6 Straight chain or branched chain alkyl, C 1 -C 6 straight chain or branched chain haloalkyl, or R i substituted phenyl, R i is selected from halogen (such as fluorine, chlorine, bromine or iodine), C 1 -C 6 linear or branched alkyl (preferably C 1 -C 3 linear or branched alkyl, more preferably methyl, ethyl, propyl or isopropyl), or -NR j R k (R j and R k are each independently selected from C 1 -C 4 linear or branched chain alkyl groups, more preferably methyl, ethyl, propyl or isopropyl).

当R为卤素时,所述的卤素优选为氟、氯、溴或碘。When R is halogen, said halogen is preferably fluorine, chlorine, bromine or iodine.

当R为C1-C6的直链或支链烷基时,所述的C1-C6的直链或支链烷基优选C1-C3的直链或支链烷基,进一步优选为甲基、乙基、丙基或异丙基。When R is a C 1 -C 6 straight chain or branched chain alkyl group, the C 1 -C 6 straight chain or branched chain alkyl group is preferably a C 1 -C 3 straight chain or branched chain alkyl group, further Preferred is methyl, ethyl, propyl or isopropyl.

当R为C1-C6的直链或支链卤代烷基时,所述的C1-C6的直链或支链卤代烷基优选为C1-C3的直链或支链卤代烷基,进一步优选为三氟甲基。When R is a C 1 -C 6 straight chain or branched chain haloalkyl, said C 1 -C 6 straight chain or branched chain haloalkyl is preferably a C 1 -C 3 straight chain or branched chain haloalkyl, More preferred is trifluoromethyl.

本发明中,所述的-OS(=O)2R优选为以下任一结构:氟磺酰基(-SO2F)、三氟甲磺酰基(-Tf)、甲磺酰基(-Ms)、对甲苯基磺酰基(-Ts)或氨基磺酰基(-SO2NMe2)。In the present invention, the -OS(=O) 2 R is preferably any of the following structures: fluorosulfonyl (-SO 2 F), trifluoromethanesulfonyl (-Tf), methylsulfonyl (-Ms), p-tolylsulfonyl (-Ts) or aminosulfonyl (-SO 2 NMe 2 ).

在如式III所示的烯基腈类化合物和如式IV所示的烯基磺酸酯类化合物中,R2、R3和R4各自独立地选自-H、-(CH2)x-Rm取代的C3-C10的芳基或杂芳基、或Rn取代的C1-C6的直链或支链烷基;其中,Rm和Rn各自独立地选自-H、卤素、-OH、-CN、C1-C4的直链或支链烷氧基和C1-C4的直链或支链烷基中的一种或多种;其中,所述的卤素优选为氟、氯、溴或碘;所述的C1-C4的直链或支链烷氧基优选C1-C3的直链或支链烷氧基,进一步为甲氧基、乙氧基、丙氧基或异丙氧基;所述的C1-C4的直链或支链烷基优选为C1-C3的直链或支链烷基,进一步优选为甲基、乙基、丙基或异丙基;x选自0-4之间的任一整数,如0、1、2或3。In the alkenyl nitrile compound shown in formula III and the alkenyl sulfonate compound shown in formula IV, R 2 , R 3 and R 4 are each independently selected from -H, -(CH 2 )xR m substituted C 3 -C 10 aryl or heteroaryl, or R n substituted C 1 -C 6 straight or branched chain alkyl; wherein, R m and R n are each independently selected from -H, One or more of halogen, -OH, -CN, C 1 -C 4 linear or branched alkoxy and C 1 -C 4 linear or branched alkyl; wherein the halogen It is preferably fluorine, chlorine, bromine or iodine; the C 1 -C 4 linear or branched alkoxy is preferably a C 1 -C 3 linear or branched alkoxy, further methoxy, ethyl Oxygen, propoxy or isopropoxy; the C 1 -C 4 straight chain or branched chain alkyl is preferably C 1 -C 3 straight chain or branched chain alkyl, more preferably methyl, Ethyl, propyl or isopropyl; x is selected from any integer between 0-4, such as 0, 1, 2 or 3.

其中,所述的-(CH2)x-Rm取代的C3-C10的芳基或杂芳基中,所述的C3-C10的芳基或杂芳基优选C6-C10的芳基,如苯基或萘基。Wherein, among the C 3 -C 10 aryl or heteroaryl substituted by -(CH 2 )xR m , the C 3 -C 10 aryl or heteroaryl is preferably C 6 -C 10 Aryl such as phenyl or naphthyl.

其中,所述的Rn取代的C1-C6的直链或支链烷基中,所述的C1-C6的直链或支链烷基优选为C1-C3的直链或支链烷基,进一步优选为甲基、乙基、丙基或异丙基。Wherein, in the C 1 -C 6 straight chain or branched chain alkyl substituted by R n , the C 1 -C 6 straight chain or branched chain alkyl is preferably a C 1 -C 3 straight chain or branched alkyl, more preferably methyl, ethyl, propyl or isopropyl.

或者,R2与R3、或R2与R4共同构成一个5-10元的单环或多环碳环或碳杂环,所述的碳杂环含有1-4个选自O、N和S的杂原子;所述的5-10元的单环或多环碳环或碳杂环可为饱和或半饱和环;且其可进一步被Rn取代。Alternatively, R 2 and R 3 , or R 2 and R 4 jointly form a 5-10 membered monocyclic or polycyclic carbocycle or carboheterocycle, and the carboheterocycle contains 1-4 members selected from O, N and S heteroatoms; the 5-10 membered monocyclic or polycyclic carbocyclic or carboheterocyclic rings may be saturated or semi-saturated rings; and they may be further substituted by R n .

其中,所述的5-10元的单环或多环碳环优选单环或双环碳环,进一步优选为环己烯或苯并环己烯。Wherein, the 5-10 membered monocyclic or polycyclic carbocycle is preferably monocyclic or bicyclic carbocycle, more preferably cyclohexene or benzocyclohexene.

本发明中,如式III所示的烯基腈类化合物和如式IV所示的烯基磺酸酯类化合物中,其可为Z型和/或E型,无需任何限定。In the present invention, among the alkenyl nitrile compound shown in formula III and the alkenyl sulfonate compound shown in formula IV, it can be Z type and/or E type without any limitation.

本发明中,所述的如式IV所示的烯基磺酸酯类化合物和如式III所示的烯基腈类化合物进一步优选为如下任意一对化合物:In the present invention, the alkenyl sulfonate compound shown in formula IV and the alkenyl nitrile compound shown in formula III are further preferably any pair of compounds as follows:

本发明中,如无特别限定,除所用底物不同以外,所述的如式III所示的烯基腈类化合物的制备方法中采用的各个反应参数和条件均同前所述,即:In the present invention, unless otherwise specified, except that the substrate used is different, each reaction parameter and condition adopted in the preparation method of the alkenyl nitrile compound shown in the formula III are the same as previously described, namely:

所述的如式III所示的烯基腈类化合物的制备方法中,所述的交叉偶联反应在惰性气体保护体系下进行,所述的惰性保护气体可为氮气、氦气、氩气和氖气中的一种或多种。In the preparation method of described alkenyl nitrile compounds shown in formula III, described cross-coupling reaction is carried out under inert gas protection system, and described inert protection gas can be nitrogen, helium, argon and One or more of neon gases.

所述的如式III所示的烯基腈类化合物的制备方法中,所述的添加剂DMAP的用量可为本领域常规所用;本发明优选所述的如式IV所示的烯基磺酸酯类化合物与DMAP的摩尔比为1:0.1-1:10,更优选为1:1-1:1.5。In the preparation method of the described alkenyl nitrile compound shown in formula III, the consumption of described additive DMAP can be routinely used in the art; The present invention preferably described alkenyl sulfonate shown in formula IV The molar ratio of quasi-compound to DMAP is 1:0.1-1:10, more preferably 1:1-1:1.5.

所述的如式III所示的烯基腈类化合物的制备方法中,除所述的添加剂DMAP外,还可加入其他添加剂,所述的其他添加剂为季铵盐和/或无机盐;其中,所述的季铵盐优选四乙基碘化铵;所述的无机盐优选碘化钠、碘化钾和碘化锂中一种或多种,更优选碘化钾。In the described preparation method of the alkenyl nitrile compound shown in formula III, except described additive DMAP, also can add other additive, described other additive is quaternary ammonium salt and/or inorganic salt; Wherein, The quaternary ammonium salt is preferably tetraethylammonium iodide; the inorganic salt is preferably one or more of sodium iodide, potassium iodide and lithium iodide, more preferably potassium iodide.

所述的如式III所示的烯基腈类化合物的制备方法中,当所述反应体系中还包含季铵盐和/或无机盐时,所述的季铵盐和/或无机盐的用量可为本领域常规所用;本发明优选所述的如式IV所示的烯基磺酸酯类化合物与所述的季铵盐和/或无机盐的摩尔比为1:0.1-1:10,更优选为1:0.5-1:1。In the described preparation method of alkenyl nitrile compound shown in formula III, when also comprising quaternary ammonium salt and/or inorganic salt in the described reaction system, the consumption of described quaternary ammonium salt and/or inorganic salt It can be routinely used in the art; the preferred molar ratio of the alkenyl sulfonate compound shown in formula IV in the present invention to the quaternary ammonium salt and/or inorganic salt is 1:0.1-1:10, More preferably 1:0.5-1:1.

所述的如式III所示的烯基腈类化合物的制备方法中,所述的金属锌的用量可为本领域此类反应常规所用;本发明优选所述的如式IV所示的烯基磺酸酯类化合物与所述的金属锌的摩尔比为1:0.01-1:10,更优选为1:0.1-1:1,进一步优选为1:0.2-1:0.4。In the preparation method of described alkenyl nitrile compound shown in formula III, the consumption of described metal zinc can be conventionally used for this type of reaction in the art; The present invention preferably described alkenyl compound shown in formula IV The molar ratio of the sulfonate compound to the metal zinc is 1:0.01-1:10, more preferably 1:0.1-1:1, further preferably 1:0.2-1:0.4.

所述的如式III所示的烯基腈类化合物的制备方法中,所述的镍配合物可为本领域该类交叉偶联反应常规所用,其可以已制备得到的本领域熟知的常规适用的镍前体催化剂与其常规适用配体的金属配合物形式参与反应,此时亦可不再另加其他配体;也可以将本领域熟知的常规适用的镍前体催化剂与其常规适用配体在反应体系中进行原位配位后再参与反应。本发明优选所述的镍配合物为NiBr2(PPh3)2和/或NiCl2(dppf);或,本发明优选所述的镍前体催化剂选自Ni(cod)2、NiCl2、NiBr2、NiI2、NiBr2(diglyme)、NiCl2(glyme)、NiBr2(DME)、NiF2和NiCl2·6H2O中的一种或多种;例如NiBr2(DME)、NiI2和NiCl2·6H2O中的一种或多种。In the preparation method of the alkenyl nitrile compound shown in the formula III, the nickel complex can be used conventionally in this type of cross-coupling reaction in the art, and it can be prepared by conventional methods well known in the art. The metal complex form of the nickel precursor catalyst and its conventional applicable ligand participates in the reaction, and at this time, no other ligands can be added; the conventional applicable nickel precursor catalyst well known in the art and its conventional applicable ligand can also be reacted After in-situ coordination in the system, it participates in the reaction. The preferred nickel complex of the present invention is NiBr 2 (PPh 3 ) 2 and/or NiCl 2 (dppf); or, the preferred nickel precursor catalyst of the present invention is selected from Ni(cod) 2 , NiCl 2 , NiBr 2 , one or more of NiI 2 , NiBr 2 (diglyme), NiCl 2 (glyme), NiBr 2 (DME), NiF 2 and NiCl 2 ·6H 2 O; for example NiBr 2 (DME), NiI 2 and One or more of NiCl 2 ·6H 2 O.

所述的如式III所示的烯基腈类化合物的制备方法中,所述的镍配合物的用量可为本领域该类反应常规所用;本发明优选所述的如式IV所示的烯基磺酸酯类化合物与所述的镍配合物的摩尔比为1:0.01-1:1,更优选1:0.02-1:0.50,进一步优选1:0.05-1:0.10。In the preparation method of the described alkenyl nitrile compound shown in the formula III, the amount of the nickel complex can be conventionally used in this type of reaction in the art; the present invention preferably describes the alkenyl nitrile compound shown in the formula IV The molar ratio of the sulfonate compound to the nickel complex is 1:0.01-1:1, more preferably 1:0.02-1:0.50, further preferably 1:0.05-1:0.10.

所述的如式III所示的烯基腈类化合物的制备方法中,如所述反应体系中还包含所述的常规适用配体,其可为本领域该类交叉偶联反应中适用于镍催化剂的常规配体,可选自三苯基膦(PPh3)、三乙基膦、三丁基膦(TBUP)、三环己基膦(TCHP)、双二苯基膦甲烷(dppm)、二甲基苯基膦(PMe2Ph)、二苯基甲基膦(PMePh2)、1,2-双(二苯膦)乙烷(dppe)、1,3-双(二苯基膦)丙烷(dppp)、1,4-双(二苯基膦)丁烷(dppb)、1,1'-双(二苯基膦)二茂铁(dppf)、9,9-二甲基-4,5-双二苯基膦氧杂蒽(xantphos)、4,5-二(二叔丁基膦)-9,9-二甲基氧杂蒽(tBu-xantphos)和3-(二环己基膦基)-1-甲基-2-苯基-1H-吲哚(CM-phos)中的一种或多种,更优选双二苯基膦甲烷(dppm)、二苯基甲基膦(PMePh2)、1,2-双(二苯膦)乙烷(dppe)、1,3-双(二苯基膦)丙烷(dppp)、1,4-双(二苯基膦)丁烷(dppb)、1,1'-双(二苯基膦)二茂铁(dppf)和9,9-二甲基-4,5-双二苯基膦氧杂蒽(xantphos)中的一种或多种;例如二苯基甲基膦、1,1'-双(二苯基膦)二茂铁和9,9-二甲基-4,5-双二苯基膦氧杂蒽中的一种或多种。In the preparation method of the alkenyl nitrile compound shown in the described formula III, if the reaction system also includes the described conventional applicable ligand, it can be suitable for nickel in this type of cross-coupling reaction in the art. Conventional ligands for catalysts, which may be selected from triphenylphosphine (PPh 3 ), triethylphosphine, tributylphosphine (TBUP), tricyclohexylphosphine (TCHP), bisdiphenylphosphinemethane (dppm), di Methylphenylphosphine (PMe 2 Ph), Diphenylmethylphosphine (PMePh 2 ), 1,2-bis(diphenylphosphine)ethane (dppe), 1,3-bis(diphenylphosphine)propane (dppp), 1,4-bis(diphenylphosphino)butane (dppb), 1,1'-bis(diphenylphosphino)ferrocene (dppf), 9,9-dimethyl-4, 5-bis-diphenylphosphine-oxanthene (xantphos), 4,5-bis(di-tert-butylphosphine)-9,9-dimethylxanthene ( t Bu-xantphos) and 3-(dicyclohexyl One or more of phosphino)-1-methyl-2-phenyl-1H-indole (CM-phos), more preferably bis-diphenylphosphine methane (dppm), diphenylmethylphosphine ( PMePh 2 ), 1,2-bis(diphenylphosphine)ethane (dppe), 1,3-bis(diphenylphosphine)propane (dppp), 1,4-bis(diphenylphosphine)butane ( dppb), 1,1'-bis(diphenylphosphino)ferrocene (dppf) and 9,9-dimethyl-4,5-bisdiphenylphosphoxanthene (xantphos) or Various; for example one of diphenylmethylphosphine, 1,1'-bis(diphenylphosphino)ferrocene and 9,9-dimethyl-4,5-bisdiphenylphosphoxanthene one or more species.

所述的如式III所示的烯基腈类化合物的制备方法中,如所述反应体系中还包含所述的常规适用配体,所述的镍前体催化剂与所述的配体的摩尔比可为本领域该类交叉偶联反应常规所用。本发明优选摩尔比为1:1~1:10,更优选1:1~1:5,进一步优选1:1.2。In the described preparation method of the alkenyl nitrile compound shown in formula III, if also comprise described conventional suitable part in described reaction system, the mole of described nickel precursor catalyst and described part Ratios are routinely used in this type of cross-coupling reaction in the art. In the present invention, the preferred molar ratio is 1:1 to 1:10, more preferably 1:1 to 1:5, and even more preferably 1:1.2.

所述的如式III所示的烯基腈类化合物的制备方法中,所述的如式IV所示的烯基磺酸酯类化合物与所述的氰基化试剂的摩尔比可为本领域该类反应常规的摩尔比;本发明优选1:0.1-1:10,更优选1:0.5-1:2,进一步优选1:0.6-1:1.2,例如1:0.8。In the preparation method of the described alkenyl nitrile compound shown in formula III, the molar ratio of described alkenyl sulfonate compound shown in formula IV and the described cyanation reagent can be The conventional molar ratio of this type of reaction; in the present invention, it is preferably 1:0.1-1:10, more preferably 1:0.5-1:2, further preferably 1:0.6-1:1.2, for example 1:0.8.

所述的如式III所示的烯基腈类化合物的制备方法中,所述的溶剂可为本领域该类交叉偶联反应常规所用,不参与反应即可;本发明优选芳烃类溶剂、醚类溶剂、卤代烃类溶剂、腈类溶剂、酰胺类溶剂和亚砜类溶剂中的一种或多种;所述的芳烃类溶剂优选苯、甲苯和二甲苯中的一种或多种;所述的醚类溶剂优选乙醚、1,4-二氧六环和四氢呋喃中的一种或多种;所述的卤代烃类溶剂优选氯代烃类溶剂;所述的氯代烃类溶剂优选二氯甲烷、二氯乙烷和氯仿中的一种或多种;所述的腈类溶剂优选乙腈;所述的酰胺类溶剂优选N,N-二甲基甲酰胺、N,N-二甲基乙酰胺(DMA)和六甲基磷酰胺中的一种或多种;所述的亚砜类溶剂优选二甲基亚砜。所述的溶剂更优选乙腈、N,N-二甲基甲酰胺和N,N-二甲基乙酰胺中的一种或多种。In the preparation method of the alkenyl nitrile compound shown in the described formula III, the solvent can be conventionally used in this type of cross-coupling reaction in the art, and does not participate in the reaction; the present invention preferably aromatic solvent, ether One or more of solvents, halogenated hydrocarbon solvents, nitrile solvents, amide solvents and sulfoxide solvents; the aromatic hydrocarbon solvent is preferably one or more of benzene, toluene and xylene; The ether solvent is preferably one or more of ether, 1,4-dioxane and tetrahydrofuran; the halogenated hydrocarbon solvent is preferably a chlorinated hydrocarbon solvent; the chlorinated hydrocarbon solvent Preferably one or more of dichloromethane, dichloroethane and chloroform; the preferred acetonitrile of the described nitrile solvent; the preferred N, N-dimethylformamide, N, N-di One or more of methylacetamide (DMA) and hexamethylphosphoramide; the sulfoxide solvent is preferably dimethyl sulfoxide. The solvent is more preferably one or more of acetonitrile, N,N-dimethylformamide and N,N-dimethylacetamide.

所述的如式III所示的烯基腈类化合物的制备方法中,所述的溶剂的用量可为本领域该类交叉偶联反应常规所用;本发明优选所述的如式IV所示的烯基磺酸酯类化合物与所述的溶剂的摩尔体积比为0.01mmol/mL-1mmol/mL,更优选0.1mmol/mL-0.5mmol/mL。In the preparation method of the described alkenyl nitrile compound shown in formula III, the consumption of described solvent can be conventionally used in this type of cross-coupling reaction in the art; The present invention preferably described as shown in formula IV The molar volume ratio of the alkenyl sulfonate compound to the solvent is 0.01mmol/mL-1mmol/mL, more preferably 0.1mmol/mL-0.5mmol/mL.

所述的如式III所示的烯基腈类化合物的制备方法中,所述的交叉偶联反应的反应温度可为本领域该类交叉偶联反应常规所用;本发明中可为-100℃-500℃,优选0℃-150℃,更优选50℃-100℃,进一步优选60℃-80℃。In the preparation method of the alkenyl nitrile compound shown in formula III, the reaction temperature of the cross-coupling reaction can be conventionally used in this type of cross-coupling reaction in the art; in the present invention, it can be -100°C -500°C, preferably 0°C-150°C, more preferably 50°C-100°C, further preferably 60°C-80°C.

所述的如式III所示的烯基腈类化合物的制备方法中,所述的交叉偶联反应的反应进程可以采用本领域中该类交叉偶联反应所用的常规监测方法(例如TLC、HPLC或NMR)进行监测,一般以所述的如式IV所示的烯基磺酸酯类化合物消失或不再反应时为反应终点。In the preparation method of described alkenyl nitrile compounds shown in formula III, the reaction process of described cross-coupling reaction can adopt the conventional monitoring method (for example TLC, HPLC that this type of cross-coupling reaction is used in the art) or NMR) for monitoring, generally the end point of the reaction is when the alkenyl sulfonate compound shown in formula IV disappears or no longer reacts.

所述的如式III所示的烯基腈类化合物的制备方法中,所述的交叉偶联反应的反应时间可为本领域该类交叉偶联反应常规所用;本发明中优选0.1-200h,进一步优选3-12h。In the preparation method of the alkenyl nitrile compound shown in formula III, the reaction time of the cross-coupling reaction can be conventionally used in this type of cross-coupling reaction in the art; preferably 0.1-200h in the present invention, More preferably 3-12h.

所述的如式III所示的烯基腈类化合物的制备方法中,所述的制备方法在所述的交叉偶联反应结束后,优选还可包括以下后处理步骤:反应结束后,过滤,除去溶剂,柱色谱分离得到目标化合物,所述的柱色谱分离可以采用本领域中该类操作的常规方法。洗脱剂优选烷烃类溶剂与酯类溶剂的混合溶剂。其中,所述的烷烃类溶剂与所述的酯类溶剂的体积比优选100:1-1:1;所述的烷烃类溶剂优选石油醚;所述的酯类溶剂优选乙酸乙酯。In the preparation method of the described alkenyl nitrile compound shown in formula III, after the described cross-coupling reaction finishes, the described preparation method can also preferably include the following post-processing steps: after the reaction finishes, filter, The solvent is removed, and the target compound is obtained through column chromatography separation, and the column chromatography separation can adopt conventional methods of this type of operation in the art. The eluent is preferably a mixed solvent of an alkane solvent and an ester solvent. Wherein, the volume ratio of the alkane solvent to the ester solvent is preferably 100:1-1:1; the alkane solvent is preferably petroleum ether; the ester solvent is preferably ethyl acetate.

本发明进一步还提供了一种如式I所示的芳香腈类化合物或如式III所示的烯基腈类化合物,The present invention further provides an aromatic nitrile compound as shown in formula I or an alkenyl nitrile compound as shown in formula III,

其中,各取代基定义均同前所述。Wherein, the definition of each substituent is the same as above.

具体地,本发明还提供了一种如下述结构所示的芳香腈或烯基腈类化合物:Specifically, the present invention also provides an aromatic nitrile or alkenyl nitrile compound as shown in the following structure:

在不违背本领域常识的基础上,上述各优选条件,可任意组合,即得本发明各较佳实例。On the basis of not violating common knowledge in the field, the above-mentioned preferred conditions can be combined arbitrarily to obtain preferred examples of the present invention.

本发明所用试剂和原料均市售可得。The reagents and raw materials used in the present invention are all commercially available.

本发明的积极进步效果在于:本发明利用简单易得的催化体系实现了芳基磺酸酯、杂芳基磺酸酯或烯基磺酸酯的氰基化反应,具有操作简捷、反应高效、条件温和、官能团兼容性和底物普适性好等优点,为实现芳香腈或烯基腈类化合物的工业合成提供了更好的应用前景和使用价值。The positive and progressive effect of the present invention is that the present invention realizes the cyanation reaction of aryl sulfonate, heteroaryl sulfonate or alkenyl sulfonate by using a simple and easy-to-obtain catalytic system, and has the advantages of simple operation, high reaction efficiency, The advantages of mild conditions, functional group compatibility and substrate universality provide better application prospects and use value for the industrial synthesis of aromatic nitrile or alkenyl nitrile compounds.

具体实施方式Detailed ways

下面通过实施例的方式进一步说明本发明,但并不因此将本发明限制在所述的实施例范围之中。下列实施例中未注明具体条件的实验方法,按照常规方法和条件,或按照商品说明书选择。The present invention is further illustrated below by means of examples, but the present invention is not limited to the scope of the examples. For the experimental methods that do not specify specific conditions in the following examples, select according to conventional methods and conditions, or according to the product instructions.

制备例1:Preparation example 1:

通用制备过程:圆底瓶中依次加入对碘苯酚(1equiv),硼酸(1.2equiv),5%Pd/CaCO3(1.5mol%),K2CO3(2equiv),EtOH和水溶解,加热到80℃回流,TLC检测反应。恢复至室温,硅藻土过滤除去沉淀,饱和食盐水淬灭反应,乙酸乙酯萃取,有机相水洗,饱和食盐水洗,无水硫酸镁干燥,过滤浓缩后分离纯化。General preparation process: Add p-iodophenol (1 equiv), boric acid (1.2 equiv), 5% Pd/CaCO 3 (1.5 mol%), K 2 CO 3 (2 equiv), EtOH and water to dissolve in the round bottom bottle, and heat to Reflux at 80°C, and detect the reaction by TLC. Return to room temperature, filter with celite to remove the precipitate, quench the reaction with saturated brine, extract with ethyl acetate, wash the organic phase with water, wash with saturated brine, dry over anhydrous magnesium sulfate, separate and purify after filtration and concentration.

硅胶柱层析,淋洗剂:石油醚/乙酸乙酯/二氯甲烷=8:1:1到纯二氯甲烷,产物为白色固体1.81g,收率91%。m.p=81.0-82.9℃.1H NMR(400MHz,CDCl3):δ3.85(s,3H),5.47(brs,1H),6.84-6.89(m,3H),7.07(s,1H),7.12(d,J=7.6Hz,1H),7.32(dd,J=8.0Hz,1H),7.45(d,J=7.6Hz,2H).13C NMR(100MHz,CDCl3):δ55.30,112.07,112.48,115.62,119.33,128.39,129.72,133.71,142.27,155.17,159.76.IR(neat):3499,3419,3362,1597,1583,1520,1488,1412,1265,1213,1175,1107,1016,860,831,820,781,688.HRMS(ESI)calcdfor C13H13O2[M+H]+:201.0910,found 201.0910.Silica gel column chromatography, eluent: petroleum ether/ethyl acetate/dichloromethane=8:1:1 to pure dichloromethane, the product is 1.81g of white solid, yield 91%. mp=81.0-82.9℃. 1 H NMR (400MHz, CDCl 3 ): δ3.85(s,3H),5.47(brs,1H),6.84-6.89(m,3H),7.07(s,1H),7.12 (d, J=7.6Hz, 1H), 7.32 (dd, J=8.0Hz, 1H), 7.45 (d, J=7.6Hz, 2H). 13 C NMR (100MHz, CDCl 3 ): δ55.30, 112.07, 112.48 ,115.62,119.33,128.39,129.72,133.71,142.27,155.17,159.76.IR(neat):3499,3419,3362,1597,1583,1520,1488,1412,1265,1213,1175,1107,1016,860,831,820,781,688. HRMS(ESI) calcd for C 13 H 13 O 2 [M+H] + :201.0910, found 201.0910.

硅胶柱层析,淋洗剂:石油醚/乙酸乙酯/二氯甲烷=6:1:1到石油醚/二氯甲烷=1:1,后用二氯甲烷/正己烷重结晶,产物为白色固体1.09g,收率62%。m.p=172.4-174.2℃.1H NMR(400MHz,DMSO-d6):δ6.81(d,J=7.6Hz,2H),7.44-7.45(m,1H),7.53-7.55(m,3H),7.61(s,1H),9.50(s,1H).13C NMR(100MHz,DMSO-d6):δ115.61,118.52,125.98,126.42,126.66,127.29,141.62,156.72.IR(neat):3386,3096,3029,1597,1532,1500,1444,1372,1250,1199,1181,1110,1009,863,833,800,774,714cm-1.HRMS(EI)calcd forC10H8OS[M]+:176.0296,found 176.0295.Silica gel column chromatography, eluent: petroleum ether/ethyl acetate/dichloromethane=6:1:1 to petroleum ether/dichloromethane=1:1, after recrystallization with dichloromethane/n-hexane, the product is White solid 1.09g, yield 62%. mp=172.4-174.2℃. 1 H NMR (400MHz, DMSO-d 6 ): δ6.81(d, J=7.6Hz, 2H), 7.44-7.45(m, 1H), 7.53-7.55(m, 3H) ,7.61(s,1H),9.50(s,1H). 13 C NMR(100MHz,DMSO-d 6 ):δ115.61,118.52,125.98,126.42,126.66,127.29,141.62,156.72.IR(neat):3386, 3096,3029,1597,1532,1500,1444,1372,1250,1199,1181,1110,1009,863,833,800,774,714cm -1 .HRMS(EI) calcd for C 10 H 8 OS[M] + :176.0296,found 295.76.

制备例2:Preparation example 2:

圆底瓶中酚(1equiv)溶于乙酸乙酯中,冰水浴下加入Et3N(2equiv),MsCl(1.3equiv),加完后撤去冰水浴,于室温下反应,TLC检测反应完全。加入水淬灭反应,乙酸乙酯萃取,有机相水洗,无水硫酸镁干燥,硅胶过滤,滤液浓缩后分离纯化。Phenol (1equiv) was dissolved in ethyl acetate in a round bottom flask, Et 3 N (2equiv), MsCl (1.3equiv) was added in an ice-water bath, and the ice-water bath was removed after addition, and reacted at room temperature, and the reaction was complete by TLC. Water was added to quench the reaction, extracted with ethyl acetate, the organic phase was washed with water, dried over anhydrous magnesium sulfate, filtered through silica gel, and the filtrate was concentrated and then separated and purified.

硅胶柱层析,淋洗剂:石油醚/乙酸乙酯=4:1,产物为浅黄色液体,收率98%。1HNMR(400MHz,CDCl3):δ0.93(t,J=7.2Hz,3H),1.32-1.38(m,2H),1.55-1.63(m,2H),2.61(t,J=7.6Hz,2H),3.11(s,3H),7.17-7.26(m,4H).13C NMR(100MHz,CDCl3):δ13.83,22.21,33.44,34.94,37.09,121.63,129.79,142.28,147.18.IR(neat):3029,2957,2932,2860,1503,1365,1330,1197,1173,1147,1113,1018,968,865,841,814,776,740,681.HRMS(ESI)calcd for C11H20NO3S[M+NH4]+:246.1158,found 246.1157.Silica gel column chromatography, eluent: petroleum ether/ethyl acetate=4:1, the product was a light yellow liquid with a yield of 98%. 1 HNMR (400MHz, CDCl 3 ): δ0.93(t, J=7.2Hz, 3H), 1.32-1.38(m, 2H), 1.55-1.63(m, 2H), 2.61(t, J=7.6Hz, 2H), 3.11(s, 3H), 7.17-7.26(m, 4H). 13 C NMR (100MHz, CDCl 3 ): δ13.83, 22.21, 33.44, 34.94, 37.09, 121.63, 129.79, 142.28, 147.18.IR (neat):3029,2957,2932,2860,1503,1365,1330,1197,1173,1147,1113,1018,968,865,841,814,776,740,681.HRMS(ESI)calcd for C 11 H 20 NO 3 S[M+NH 4 ] + :246.1158, found 246.1157.

硅胶柱层析,淋洗剂:石油醚/乙酸乙酯/二氯甲烷=4:1:1,产物为白色固体,收率94%。m.p=53.8-55.1℃.1H NMR(400MHz,CDCl3):δ2.35(s,3H),3.14(s,3H),3.86(s,3H),6.74-6.77(m,1H),6.81(d,J=1.6Hz,1H),7.16(d,J=8.4Hz,1H).13C NMR(100MHz,CDCl3):δ21.35,37.93,55.75,113.56,121.38,123.95,136.02,138.48,150.81.IR(neat):3037,3013,2933,2843,1602,1505,1473,1415,1356,1290,1196,1174,1145,1110,1035,966,850,812,786,684.HRMS(ESI)calcd for C9H16NO4S[M+NH4]+:234.0794,found 234.0792.Silica gel column chromatography, eluent: petroleum ether/ethyl acetate/dichloromethane=4:1:1, the product was a white solid, and the yield was 94%. mp=53.8-55.1℃. 1 H NMR (400MHz, CDCl 3 ): δ2.35(s,3H),3.14(s,3H),3.86(s,3H),6.74-6.77(m,1H),6.81 (d, J=1.6Hz, 1H), 7.16 (d, J=8.4Hz, 1H). 13 C NMR (100MHz, CDCl 3 ): δ21.35, 37.93, 55.75, 113.56, 121.38, 123.95, 136.02, 138.48 ,150.81.IR(neat):3037,3013,2933,2843,1602,1505,1473,1415,1356,1290,1196,1174,1145,1110,1035,966,850,812,786,684.HRMS(ESI)calcd for C 9 H 1 NO 4 S[M+NH 4 ] + :234.0794, found 234.0792.

二氯甲烷/正己烷重结晶,产物为白色固体,收率89%。m.p=148.6-149.7℃.1HNMR(400MHz,CDCl3):δ2.39(s,3H),3.15(s,3H),7.24(d,J=7.6Hz,2H),7.32(d,J=8.4Hz,2H),7.44(d,J=7.2Hz,2H),7.59(d,J=7.6Hz,2H).13C NMR(100MHz,CDCl3):21.04,37.25,122.18,126.89,128.38,129.57,136.75,137.58,140.50,148.31.IR(neat):3039,3026,2944,1611,1491,1360,1334,1173,1151,973,964,867,852,811,788,720,655.HRMS(ESI)calcd for C14H18NO3S[M+NH4]+:280.1002,found 280.0998.The product was recrystallized from dichloromethane/n-hexane, and the product was a white solid with a yield of 89%. mp=148.6-149.7℃. 1 HNMR (400MHz, CDCl 3 ): δ2.39(s, 3H), 3.15(s, 3H), 7.24(d, J=7.6Hz, 2H), 7.32(d, J= 8.4Hz, 2H), 7.44(d, J=7.2Hz, 2H), 7.59(d, J=7.6Hz, 2H). 13 C NMR(100MHz, CDCl 3 ): 21.04, 37.25, 122.18, 126.89, 128.38, 129.57,136.75,137.58,140.50,148.31.IR (neat): 3039,3026,2944,1611,1491,1360,1334,1173,1151,973,964,867,852,811,788,720,655.HRMS3 for CI8 H1c +NH 4 ] + :280.1002,found 280.0998.

二氯甲烷/正己烷重结晶,产物为白色固体,收率95%。m.p=83.4-85.0℃.1H NMR(400MHz,CDCl3,Me4Si):δ3.16(s,3H),3.86(s,3H),6.91(d,J=8.4Hz,1H),7.07(s,1H),7.13(d,J=7.6Hz,1H),7.33-7.38(m,3H),7.59-7.61(m,2H).13C NMR(100MHz,CDCl3,Me4Si):37.31,55,25,112.92,113.01,119.54,122.20,128.67,129.89,140.42,141.15,148.59,159.94.IR(neat):2962,2938,2838,1608,1576,1482,1356,1333,1299,1215,1171,1147,1056,972,963,862,838,793,735,721,696.HRMS(ESI)calcd for C14H18NO4S[M+NH4]+:296.0951,found 296.0948.The product was recrystallized from dichloromethane/n-hexane, and the product was a white solid with a yield of 95%. mp=83.4-85.0℃. 1 H NMR (400MHz, CDCl 3 , Me 4 Si): δ3.16(s, 3H), 3.86(s, 3H), 6.91(d, J=8.4Hz, 1H), 7.07 (s, 1H), 7.13 (d, J=7.6Hz, 1H), 7.33-7.38 (m, 3H), 7.59-7.61 (m, 2H). 13 C NMR (100MHz, CDCl 3 , Me 4 Si): 37.31,55,25,112.92,113.01,119.54,122.20,128.67,129.89,140.42,141.15,148.59,159.94.IR(neat):2962,2938,2838,1608,1576,1782,1356,193 ,1147,1056,972,963,862,838,793,735,721,696.HRMS(ESI)calcd for C 14 H 18 NO 4 S[M+NH 4 ] + :296.0951,found 296.0948.

硅胶柱层析,二氯甲烷/正己烷重结晶,产物为白色固体,收率95%。m.p=120.8-122.2℃.1H NMR(400MHz,DMSO-d6):δ7.27-7.31(m,2H),7.45(d,J=8.0Hz,2H),7.69-7.75(m,4H).13C NMR(100MHz,DMSO-d6):δ37.40,115.79(2JC-F=21.3Hz),122.73,128.33,128.83(3JC-F=7.5Hz),135.38(4JC-F=3.8Hz),138.31,148.56,162.08(1JC-F=242.9Hz).19FNMR(376.1MHz,DMSO-d6):δ-114.95.IR(neat):3062,3029,2944,1735,1599,1491,1370,1336,1254,1210,1182,1157,1115,1016,1006,968,945,864,825,789,739,719,653.HRMS(ESI)calcd for C13H15FNO3S[M+NH4]+:284.0751,found 284.0750.Silica gel column chromatography, dichloromethane/n-hexane recrystallization, the product is a white solid, and the yield is 95%. mp=120.8-122.2℃. 1 H NMR (400MHz, DMSO-d 6 ): δ7.27-7.31(m, 2H), 7.45(d, J=8.0Hz, 2H), 7.69-7.75(m, 4H) .13 C NMR (100MHz, DMSO-d 6 ): δ37.40, 115.79 ( 2 J CF =21.3Hz), 122.73, 128.33, 128.83 ( 3 J CF =7.5Hz), 135.38 ( 4 J CF =3.8Hz), 138.31 ,148.56,162.08( 1 J CF =242.9Hz). 19 FNMR(376.1MHz,DMSO-d 6 ):δ-114.95.IR(neat):3062,3029,2944,1735,1599,1491,1370,1336, 1254,1210,1182,1157,1115,1016,1006,968,945,864,825,789,739,719,653.HRMS(ESI)calcd for C 13 H 15 FNO 3 S[M+NH 4 ] + :284.0751,found 284.0750.

二氯甲烷/正己烷重结晶,产物为白色固体,收率84%。m.p=160.8-162.2℃.1HNMR(400MHz,DMSO-d6):δ3.41(s,3H),7.40(d,J=8.0Hz,2H),7.57(d,J=3.6Hz,1H),7.65(d,J=2.0Hz,1H),7.82(d,J=8.0Hz,2H),7.91(s,1H).13C NMR(100MHz,DMSO-d6):37.36,121.72,122.70,126.22,127.36,127.66,134.34,140.15,148.06.IR(neat):3096,3037,3024,2941,1600,1530,1495,11372,1327,1203,1182,1155,1107,1011,970,863,850,819,792,780,729,709.HRMS(ESI)calcd for C11H14NO3S2[M+NH4]+:272.0410,found272.0410.The product was recrystallized from dichloromethane/n-hexane, and the product was a white solid with a yield of 84%. mp=160.8-162.2℃. 1 HNMR (400MHz, DMSO-d 6 ): δ3.41(s, 3H), 7.40(d, J=8.0Hz, 2H), 7.57(d, J=3.6Hz, 1H) , 7.65(d, J=2.0Hz, 1H), 7.82(d, J=8.0Hz, 2H), 7.91(s, 1H). 13 C NMR(100MHz, DMSO-d 6 ): 37.36, 121.72, 122.70, 126.22,127.36,127.66,134.34,140.15,148.06.IR(neat):3096,3037,3024,2941,1600,1530,1495,11372,1327,1203,1182,1155,1107,1011,970,863,850,819,792,780,729,709.HRMS(ESI )calcd for C 11 H 14 NO 3 S 2 [M+NH 4 ] + :272.0410,found272.0410.

制备例3:Preparation example 3:

圆底瓶中对醛基苯酚(1.22g,10mmol)溶于30mL的乙酸乙酯中,0℃下加入Et3N(2.8mL,20mmol),MsCl(1.0mL,13mmol),加完后撤去冰水浴,于室温下反应,TLC检测反应完全。加入水淬灭反应,乙酸乙酯萃取,有机相水洗,饱和食盐水洗,无水硫酸镁干燥,硅胶过滤,滤液浓缩后进行下一步反应。Dissolve p-aldehyde phenol (1.22g, 10mmol) in 30mL of ethyl acetate in a round bottom flask, add Et 3 N (2.8mL, 20mmol) and MsCl (1.0mL, 13mmol) at 0°C, remove the ice after the addition is complete Water bath, react at room temperature, and TLC detects that the reaction is complete. Water was added to quench the reaction, extracted with ethyl acetate, the organic phase was washed with water, washed with saturated brine, dried over anhydrous magnesium sulfate, filtered through silica gel, and the filtrate was concentrated for the next step of reaction.

将上步产物溶于20mL MeOH与20mL DCM中,分批加入NaBH4(491.8mg,13mmol),加完后于室温下反应,TLC检测反应完全。加入饱和氯化铵淬灭反应,DCM萃取,有机相水洗,饱和食盐水洗,无水硫酸钠干燥,过滤浓缩,硅胶柱层析,淋洗剂:石油醚/乙酸乙酯=4:1,分离得到无色液体1.899g,收率95%。1H NMR(400MHz,CDCl3):δ1.05(br,1H),3.11(s,3H),4.65(s,2H),7.24(d,J=7.6Hz,2H),7.38(d,J=8.0Hz,2H).13C NMR(100MHz,CDCl3):δ37.21,64.02,121.93,128.31,140.26,148.24.IR(neat):3561,3383,3024,2939,2871,1603,1504,1412,1358,1196,1170,1144,1015,969,865,838,812,773,678.HRMS(ESI)calcd for C8H14NO4S[M+NH4]+:220.0637,found220.0638.The product from the previous step was dissolved in 20 mL MeOH and 20 mL DCM, NaBH 4 (491.8 mg, 13 mmol) was added in batches, and reacted at room temperature after the addition was complete. The reaction was complete as detected by TLC. Add saturated ammonium chloride to quench the reaction, extract with DCM, wash the organic phase with water, wash with saturated brine, dry over anhydrous sodium sulfate, filter and concentrate, silica gel column chromatography, eluent: petroleum ether/ethyl acetate=4:1, separate 1.899 g of colorless liquid was obtained, yield 95%. 1 H NMR (400MHz, CDCl 3 ): δ1.05(br, 1H), 3.11(s, 3H), 4.65(s, 2H), 7.24(d, J=7.6Hz, 2H), 7.38(d, J =8.0Hz, 2H). 13 C NMR (100MHz, CDCl 3 ): δ37.21, 64.02, 121.93, 128.31, 140.26, 148.24. IR (neat): 3561, 3383, 3024, 2939, 2871, 1603, 1504, 1412,1358,1196,1170,1144,1015,969,865,838,812,773,678.HRMS(ESI)calcd for C 8 H 14 NO 4 S[M+NH 4 ] + :220.0637,found220.0638.

制备例4:Preparation example 4:

氩气保护下,向标准的Schlenk反应管中加入4-phenylcyclohexan-1-one(1.39g,8和THF(30mL)。反应液冷却至-15℃,一次性加入KHMDS(0.5M in toluene,17.6mL,8.8mmol),加完后于-15℃搅拌1h。然后于-15℃下一次性加入4-甲苯磺酸酐(2.87g,8.8mmol)。加完后于-15℃搅拌0.5h,然后恢复至室温反应,TLC检测反应完全后,加饱和NaHCO3淬灭反应,EA萃取,有机相用水洗,饱和食盐水洗,无水硫酸钠干燥,过滤,滤液浓缩后柱层析。淋洗剂:石油醚/乙酸乙酯=15:1,得到白色固体,乙酸乙酯/正乙烷重结晶,得白色固体841.6mg,收率32%。M.p.:100.8-101.5℃.1H NMR(400MHz,CDCl3):δ1.80-1.87(m,1H),1.93-1.96(m,1H),2.16-2.22(m,2H),2.26-2.33(m,2H),2.47(s,3H),2.71-2.76(m,1H),7.17-7.23(m,3H),7.26-7.32(m,2H),7.36(d,J=8.0Hz,2H),7.83(d,J=7.2Hz,2H).13C NMR(100MHz,CDCl3):δ21.67,27.85,29.65,31.57,38.87,116.4,126.35,126.71,128.20,128.44,129.66,133.48,144.92,145.18,147.94.IR(neat):3060,3029,2920,2892,2840,1735,1681,1593,1493,1371,1290,1190,1174,1081,1036,891,853,815,763,743,696,688,675.HRMS(ESI)calcd for C19H24NO3S[M+NH4]+:346.1471,found346.1466.Under argon protection, 4-phenylcyclohexan-1-one (1.39g, 8 and THF (30mL) were added to a standard Schlenk reaction tube. The reaction solution was cooled to -15°C, and KHMDS (0.5M in toluene, 17.6 mL, 8.8mmol), and stirred at -15°C for 1h after the addition was completed. Then, 4-toluenesulfonic anhydride (2.87g, 8.8mmol) was added at one time at -15°C. After the addition was completed, stirred at -15°C for 0.5h, then Return to room temperature and react. After TLC detects that the reaction is complete, add saturated NaHCO 3 to quench the reaction, extract with EA, wash the organic phase with water, wash with saturated saline, dry over anhydrous sodium sulfate, filter, and concentrate the filtrate before column chromatography. Eluent: Petroleum ether/ethyl acetate=15:1, a white solid was obtained, and ethyl acetate/n-ethane was recrystallized to obtain 841.6 mg of a white solid, with a yield of 32%. Mp: 100.8-101.5°C. 1 H NMR (400MHz, CDCl 3 ): δ1.80-1.87(m,1H),1.93-1.96(m,1H),2.16-2.22(m,2H),2.26-2.33(m,2H),2.47(s,3H),2.71- 2.76(m,1H),7.17-7.23(m,3H),7.26-7.32(m,2H),7.36(d,J=8.0Hz,2H),7.83(d,J=7.2Hz,2H). 13 C NMR (100MHz, CDCl 3 ): δ21.67, 27.85, 29.65, 31.57, 38.87, 116.4, 126.35, 126.71, 128.20, 128.44, 129.66, 133.48, 144.92, 145.18, 147.94. IR (neat): 32960, 2920,2892,2840,1735,1681,1593,1493,1371,1290,1190,1174,1081,1036,891,853,815,763,743,696,688,675.HRMS(ESI)calcd for C 19 H 264 NO 34 S[ M + NH]: 4 , found 346.1466.

制备例5:Preparation example 5:

氩气保护下,向标准的Schlenk反应管中加入1-acetonaphthone(1.36g,8mmol)和THF(24mL)。反应液冷却至-20℃,逐滴加入1.0M tBuOK(1.27g,11.2mmol)的THF(11mL)溶液,10min加完。加完后于0℃搅拌1.5h。然后冷却至-20℃,一次性加入4-甲苯磺酸酐(3.13g,9.6mmol)。加完后于-20℃搅拌1h,0℃搅拌6h,然后恢复至室温反应,TLC检测反应完全后,加饱和NaHCO3淬灭反应,EA萃取,有机相用水洗,饱和食盐水洗,无水硫酸钠干燥,过滤,滤液浓缩后柱层析。淋洗剂:石油醚/乙酸乙酯=20:1,得到黄色液体1.77g,收率54%。1H NMR(400MHz,CDCl3):δ2.24(s,3H),5.25(d,J=1.6Hz,1H),5.54(d,J=2.0Hz,1H),6.90(d,J=8.0Hz,2H),7.28-7.32(t,J=7.2Hz,1H),7.37(d,J=7.2Hz,1H),7.41-7.45(m,3H),7.71-7.75(m,2H),8.00-8.02(m,1H).13C NMR(100MHz,CDCl3):δ21.36,108.94,124.62,125.31,125.92,126.56,127.87,127.94,127.99,128.84,129.81,130.39,131.42,132.82,133.17,144.39,152.90.IR(neat):3117,3052,2944,1655,1590,1505,1451,1364,1234,1190,1171,1125,1089,922,900,851,798,777,731,682,655.HRMS(ESI)calcd forC19H20NO3S[M+NH4]+:342.1158,found 342.1151.Under argon protection, 1-acetonaphthone (1.36 g, 8 mmol) and THF (24 mL) were added to a standard Schlenk reaction tube. The reaction solution was cooled to -20°C, and a solution of 1.0M tBuOK (1.27g, 11.2mmol) in THF ( 11mL ) was added dropwise, and the addition was completed within 10min. Stir at 0°C for 1.5h after the addition is complete. It was then cooled to -20°C, and 4-toluenesulfonic anhydride (3.13 g, 9.6 mmol) was added in one portion. After the addition, stir at -20°C for 1h, then stir at 0°C for 6h, then return to room temperature and react. After TLC detects that the reaction is complete, add saturated NaHCO 3 to quench the reaction, extract with EA, wash the organic phase with water, wash with saturated saline, and anhydrous sulfuric acid Dry over sodium, filter, and concentrate the filtrate for column chromatography. Eluent: petroleum ether/ethyl acetate=20:1, 1.77 g of yellow liquid was obtained, yield 54%. 1 H NMR (400MHz, CDCl 3 ): δ2.24(s, 3H), 5.25(d, J=1.6Hz, 1H), 5.54(d, J=2.0Hz, 1H), 6.90(d, J=8.0 Hz, 2H), 7.28-7.32(t, J=7.2Hz, 1H), 7.37(d, J=7.2Hz, 1H), 7.41-7.45(m, 3H), 7.71-7.75(m, 2H), 8.00 -8.02(m,1H) .13 C NMR(100MHz,CDCl 3 ):δ21.36,108.94,124.62,125.31,125.92,126.56,127.87,127.94,127.99,128.84,129.81,130.39,131.42,913.4 152.90.IR (neat): 3117,3052,2944,1655,1590,1505,1451,1364,1234,1190,1171,1125,1089,922,900,851,798,777,731,682,655.HRMS (ESI)calcd for C 3 NH 4 ] + :342.1158,found 342.1151.

实施例1化合物(1a)Example 1 compound (1a)

在充满N2的手套箱中,向具有封口塞的小瓶中依次加入NiCl2·6H2O(5.9mg,0.025mmol),dppf(16.6mg,0.03mmol),Zn(6.5mg,0.1mmol),Zn(CN)2(47.0mg,0.4mmol),DMAP(91.6mg,0.75mmol),4-乙酰基苯基甲磺酸酯(107.1mg,0.5mmol),CH3CN(5mL)。盖好盖子后移出手套箱,直接置于80℃油浴中加热反应,12h后冷至室温,TLC检测后硅胶过滤,乙酸乙酯洗,浓缩后柱层析。淋洗剂:石油醚/乙酸乙酯=5:1,产物为白色固体67.8mg,收率93%,1H NMR纯度大于98%。1H NMR(400MHz,CDCl3):δ2.67(s,3H),7.80(d,J=8.4Hz,2H),8.07(d,J=8.4Hz,2H).13C NMR(100MHz,CDCl3):δ26.61,116.12,117.77,128.53,132.37,139.70,196.43.In a glove box filled with N 2 , NiCl 2 6H 2 O (5.9 mg, 0.025 mmol), dppf (16.6 mg, 0.03 mmol), Zn (6.5 mg, 0.1 mmol), Zn(CN) 2 (47.0 mg, 0.4 mmol), DMAP (91.6 mg, 0.75 mmol), 4-acetylphenyl mesylate (107.1 mg, 0.5 mmol), CH 3 CN (5 mL). After covering the lid, remove it from the glove box, place it directly in an oil bath at 80°C for heating reaction, cool to room temperature after 12 hours, filter on silica gel after TLC detection, wash with ethyl acetate, concentrate and perform column chromatography. Eluent: petroleum ether/ethyl acetate=5:1, the product was 67.8 mg of white solid, the yield was 93%, and the 1 H NMR purity was greater than 98%. 1 H NMR (400MHz, CDCl 3 ): δ2.67(s, 3H), 7.80(d, J=8.4Hz, 2H), 8.07(d, J=8.4Hz, 2H). 13 C NMR (100MHz, CDCl 3 ): δ26.61, 116.12, 117.77, 128.53, 132.37, 139.70, 196.43.

实施例2化合物(1b)Example 2 Compound (1b)

在充满N2的手套箱中,向具有封口塞的小瓶中依次加入NiCl2·6H2O(11.9mg,0.05mmol),dppf(33.3mg,0.06mmol),Zn(13.1mg,0.2mmol),Zn(CN)2(47.0mg,0.4mmol),DMAP(91.6mg,0.75mmol),KI(41.5mg,0.25mmol),4-甲氧基苯基甲磺酸酯(107.1mg,0.5mmol),DMF(5mL)。盖好盖子后移出手套箱,直接置于80℃油浴中加热反应,12h后冷至室温,TLC检测反应。反应结束后水淬灭,Et2O萃取三次,有机相水洗,饱和食盐水洗,合并水相,Et2O反萃取两次,合并有机相,无水硫酸镁干燥,过滤浓缩后柱层析。硅胶柱层析,淋洗剂:石油醚/乙酸乙酯=10:1,产物为白色固体53.6mg,收率81%,1H NMR纯度大于98%。1HNMR(400MHz,CDCl3):δ3.86(s,3H),6.95(d,J=8.8Hz,2H),7.58(d,J=9.2Hz,2H).13C NMR(100MHz,CDCl3):δ55.45,103.81,114.67,119.15,133.87,162.76.In a glove box filled with N 2 , NiCl 2 6H 2 O (11.9mg, 0.05mmol), dppf (33.3mg, 0.06mmol), Zn (13.1mg, 0.2mmol), Zn(CN) 2 (47.0mg, 0.4mmol), DMAP (91.6mg, 0.75mmol), KI (41.5mg, 0.25mmol), 4-methoxyphenyl mesylate (107.1mg, 0.5mmol), DMF (5 mL). After covering the lid, remove it from the glove box, place it directly in an 80°C oil bath for heating reaction, cool to room temperature after 12 hours, and detect the reaction by TLC. After the reaction, quenched with water, extracted three times with Et 2 O, washed the organic phase with water, washed with saturated brine, combined the aqueous phase, back-extracted twice with Et 2 O, combined the organic phase, dried over anhydrous magnesium sulfate, filtered and concentrated, and then column chromatography. Silica gel column chromatography, eluent: petroleum ether/ethyl acetate=10:1, the product was 53.6 mg of white solid, the yield was 81%, and the 1 H NMR purity was greater than 98%. 1 HNMR (400MHz, CDCl 3 ): δ3.86(s, 3H), 6.95(d, J=8.8Hz, 2H), 7.58(d, J=9.2Hz, 2H). 13 C NMR (100MHz, CDCl 3 ): δ55.45, 103.81, 114.67, 119.15, 133.87, 162.76.

实施例3化合物(1c)Example 3 Compound (1c)

采用实施例2方案,80℃下反应12h。硅胶板层析,淋洗剂:石油醚/乙酸乙酯=40:1,产物为浅黄色液体20.4mg,收率35%而核磁收率为72%。1H NMR纯度大于98%。1H NMR(400MHz,CDCl3):δ2.42(s,3H),7.27(d,J=7.2Hz,2H),7.54(d,J=7.2Hz,2H).13C NMR(100MHz,CDCl3):δ21.77,109.28,119.11,129.79,132.00,143.65.Using the scheme of Example 2, the reaction was carried out at 80° C. for 12 h. Silica gel plate chromatography, eluent: petroleum ether/ethyl acetate=40:1, the product was 20.4 mg of light yellow liquid, the yield was 35% and the NMR yield was 72%. 1 H NMR purity greater than 98%. 1 H NMR (400MHz, CDCl 3 ): δ2.42(s, 3H), 7.27(d, J=7.2Hz, 2H), 7.54(d, J=7.2Hz, 2H). 13 C NMR (100MHz, CDCl 3 ): δ21.77, 109.28, 119.11, 129.79, 132.00, 143.65.

实施例4化合物(1d)Example 4 compound (1d)

采用实施例2方案,80℃下反应12h。硅胶板层析,淋洗剂:石油醚/乙酸乙酯/二氯甲烷=100:3:1,产物为浅黄色液体33.2mg,收率42%而核磁收率为71%。1H NMR纯度大于98%。1H NMR(400MHz,CDCl3):δ0.93(t,J=7.2Hz,3H),1.29-1.39(m,2H),1.57-1.64(m,2H),2.66(t,J=7.6Hz,2H),7.27(d,J=8.0Hz,2H),7.55(d,J=8.0Hz,2H).13C NMR(100MHz,CDCl3):δ13.78,22.18,33.01,35.74,109.39,111.13,129.14,132.03,148.52。Using the scheme of Example 2, the reaction was carried out at 80° C. for 12 hours. Silica gel plate chromatography, eluent: petroleum ether/ethyl acetate/dichloromethane=100:3:1, the product was 33.2 mg of light yellow liquid, the yield was 42% and the NMR yield was 71%. 1 H NMR purity greater than 98%. 1 H NMR (400MHz, CDCl 3 ): δ0.93(t, J=7.2Hz, 3H), 1.29-1.39(m, 2H), 1.57-1.64(m, 2H), 2.66(t, J=7.6Hz , 2H), 7.27(d, J=8.0Hz, 2H), 7.55(d, J=8.0Hz, 2H). 13 C NMR (100MHz, CDCl 3 ): δ13.78, 22.18, 33.01, 35.74, 109.39, 111.13, 129.14, 132.03, 148.52.

实施例5化合物(1e)Example 5 compound (1e)

采用实施例1方案,80℃下反应12h。硅胶柱层析,淋洗剂:石油醚/乙酸乙酯=3:1,产物为无色液体40.7mg,收率61%。1H NMR纯度大于98%。1H NMR(400MHz,CDCl3):δ2.70(brs,1H),4.76(s,2H),7.47(d,J=8.0Hz,2H),7.62(d,J=8.0Hz,2H)Using the protocol of Example 1, the reaction was carried out at 80° C. for 12 h. Silica gel column chromatography, eluent: petroleum ether/ethyl acetate=3:1, the product was 40.7 mg of colorless liquid, and the yield was 61%. 1 H NMR purity greater than 98%. 1 H NMR (400MHz, CDCl 3 ): δ2.70(brs, 1H), 4.76(s, 2H), 7.47(d, J=8.0Hz, 2H), 7.62(d, J=8.0Hz, 2H)

实施例6化合物(1f)Example 6 Compound (1f)

采用实施例2方案,80℃下反应12h。硅胶板层析,淋洗剂:石油醚/乙酸乙酯/二氯甲烷=15:1:1,产物为浅黄色固体50.9mg,收率69%。1H NMR纯度大于98%。m.p=70.1-71.2℃.1H NMR(400MHz,CDCl3,Me4Si):δ2.41(s,3H),3.91(s,3H),6.78(s,1H),6.81(d,J=8.0Hz,1H),7.41(d,J=7.6Hz,1H).13C NMR(100MHz,CDCl3,Me4Si):δ22.17,55.78,98.60,111.97,116.75,121.56,133.26,145.69,161.09.IR(neat):3070,3016,2949,2921,2845,2217,1608,1572,1503,1466,1409,1378,1302,1287,1272,1200,1164,1123,1033,929,864,742,728.HRMS(ESI)calcd for C9H10NO[M+H]+:148.0757,found 148.0752.Using the scheme of Example 2, the reaction was carried out at 80° C. for 12 h. Silica gel plate chromatography, eluent: petroleum ether/ethyl acetate/dichloromethane=15:1:1, the product was 50.9 mg of light yellow solid, and the yield was 69%. 1 H NMR purity greater than 98%. mp=70.1-71.2℃. 1 H NMR (400MHz, CDCl 3 , Me 4 Si): δ2.41(s, 3H), 3.91(s, 3H), 6.78(s, 1H), 6.81(d, J= 8.0Hz, 1H), 7.41 (d, J=7.6Hz, 1H). 13 C NMR (100MHz, CDCl 3 , Me 4 Si): δ22.17, 55.78, 98.60, 111.97, 116.75, 121.56, 133.26, 145.69, 161.09.IR(neat):3070,3016,2949,2921,2845,2217,1608,1572,1503,1466,1409,1378,1302,1287,1272,1200,1164,1123,1033,929,864,742,728. )calcd for C 9 H 10 NO[M+H] + :148.0757, found 148.0752.

实施例7化合物(1g)Example 7 compound (1g)

采用实施例1方案,80℃下反应6h。硅胶柱层析,淋洗剂:石油醚/乙酸乙酯=12:1,产物为无色液体62.8mg,收率85%。1H NMR纯度大于98%。1H NMR(400MHz,CDCl3):δ6.07(s,2H),6.87(d,J=8.0Hz,1H),7.03(s,1H),7.21(d,J=8.0Hz,1H).13C NMR(100MHz,CDCl3):δ102.13,104.77,109.00,111.24,118.74,128.07,147.91,151.42.Using the protocol of Example 1, the reaction was carried out at 80° C. for 6 h. Silica gel column chromatography, eluent: petroleum ether/ethyl acetate=12:1, the product was 62.8 mg of colorless liquid, and the yield was 85%. 1 H NMR purity greater than 98%. 1 H NMR (400MHz, CDCl 3 ): δ6.07(s, 2H), 6.87(d, J=8.0Hz, 1H), 7.03(s, 1H), 7.21(d, J=8.0Hz, 1H). 13 C NMR (100MHz, CDCl 3 ): δ102.13, 104.77, 109.00, 111.24, 118.74, 128.07, 147.91, 151.42.

实施例8化合物(1h)Example 8 compound (1h)

采用实施例1方案,80℃下反应12h。硅胶柱层析,淋洗剂:石油醚/乙酸乙酯=12:1,产物为无色液体56.2mg,收率77%。1H NMR纯度大于98%。1H NMR(400MHz,CDCl3):δ2.96(s,3H),6.86–6.88(m,2H),6.93(d,J=7.2Hz,1H),7.26(dd,J=7.6Hz,1H).13C NMR(100MHz,CDCl3):δ40.00,112.60,114.62,116.11,119.23,119.69,129.61,150.11.Using the protocol of Example 1, the reaction was carried out at 80° C. for 12 hours. Silica gel column chromatography, eluent: petroleum ether/ethyl acetate=12:1, the product was 56.2 mg of colorless liquid, and the yield was 77%. 1 H NMR purity greater than 98%. 1 H NMR (400MHz, CDCl 3 ): δ2.96(s, 3H), 6.86–6.88(m, 2H), 6.93(d, J=7.2Hz, 1H), 7.26(dd, J=7.6Hz, 1H ). 13 C NMR (100MHz, CDCl 3 ): δ40.00, 112.60, 114.62, 116.11, 119.23, 119.69, 129.61, 150.11.

实施例9化合物(1i)Example 9 Compound (1i)

采用实施例1方案,80℃下反应5h。柱层析,淋洗剂:石油醚/乙酸乙酯=10:1,产物为白色固体74.5mg,收率91%。1H NMR纯度大于98%。1H NMR(400MHz,CDCl3,Me4Si):δ3.81(s,6H),6.65(s,1H),6.75(s,2H).13C NMR(100MHz,CDCl3,Me4Si):δ55.52,105.44,109.74,113.23,118.62,160.85.Using the protocol of Example 1, the reaction was carried out at 80° C. for 5 h. Column chromatography, eluent: petroleum ether/ethyl acetate=10:1, the product was 74.5 mg of white solid, and the yield was 91%. 1 H NMR purity greater than 98%. 1 H NMR(400MHz,CDCl 3 ,Me 4 Si):δ3.81(s,6H),6.65(s,1H),6.75(s,2H). 13 C NMR(100MHz,CDCl 3 ,Me 4 Si) : δ55.52, 105.44, 109.74, 113.23, 118.62, 160.85.

实施例10化合物(1j)Example 10 Compound (1j)

采用实施例1方案,但是将配体更换为PMePh2,NiCl2·6H2O(5.9mg,0.025mmol),PMePh2(12.0mg,0.06mmol),Zinc(6.5mg,0.1mmol),Zn(CN)2(47.0mg,0.4mmol),DMAP(91.6mg,0.75mmol),4-苯甲酰基苯基甲磺酸酯(138.2mg,0.5mmol)和CH3CN(5mL),加完后于80℃反应12h。硅胶柱层析,淋洗剂:石油醚/乙酸乙酯=10:1,产物为白色固体91.5mg,收率88%。1H NMR纯度大于98%。1H NMR(400MHz,CDCl3):δ7.52(t,J=7.6Hz,2H),7.64(t,J=7.2Hz,2H),7.78-7.80(m,4H),7.88(d,J=8.4Hz,2H).13C NMR(100MHz,CDCl3):δ115.49,117.89,128.51,129.93,130.10,132.05,133.20,136.18,141.08,194.90.Using the protocol of Example 1, but replacing the ligands with PMePh 2 , NiCl 2 .6H 2 O (5.9 mg, 0.025 mmol), PMePh 2 (12.0 mg, 0.06 mmol), Zinc (6.5 mg, 0.1 mmol), Zn ( CN) 2 (47.0mg, 0.4mmol), DMAP (91.6mg, 0.75mmol), 4-benzoylphenyl mesylate (138.2mg, 0.5mmol) and CH 3 CN (5mL), after adding Reaction at 80°C for 12h. Silica gel column chromatography, eluent: petroleum ether/ethyl acetate=10:1, the product was 91.5 mg of white solid, and the yield was 88%. 1 H NMR purity greater than 98%. 1 H NMR (400MHz, CDCl 3 ): δ7.52(t, J=7.6Hz, 2H), 7.64(t, J=7.2Hz, 2H), 7.78-7.80(m, 4H), 7.88(d, J =8.4Hz, 2H). 13 C NMR (100MHz, CDCl 3 ): δ115.49, 117.89, 128.51, 129.93, 130.10, 132.05, 133.20, 136.18, 141.08, 194.90.

实施例11化合物(1k)Example 11 Compound (1k)

采用实施例1方案,80℃下反应9h。硅胶板层析,淋洗剂:石油醚/二氯甲烷=3:2到1:1,产物为白色固体52.8mg,收率82%。1H NMR纯度大于98%。1H NMR(400MHz,CDCl3):δ7.81(s,4H).13C NMR(100MHz,CDCl3):δ116.66,116.97,132.76.Using the protocol of Example 1, the reaction was carried out at 80° C. for 9 h. Silica gel plate chromatography, eluent: petroleum ether/dichloromethane=3:2 to 1:1, the product was 52.8 mg of white solid, and the yield was 82%. 1 H NMR purity greater than 98%. 1 H NMR (400MHz, CDCl 3 ): δ7.81(s, 4H). 13 C NMR (100MHz, CDCl 3 ): δ116.66, 116.97, 132.76.

实施例12化合物(1l)Example 12 compound (11)

采用实施例1方案,80℃下反应3h。硅胶柱层析,淋洗剂:石油醚/乙酸乙酯=10:1,产物为白色固体73.9mg,收率92%。1H NMR纯度大于98%。1H NMR(400MHz,CDCl3):δ3.97(s,3H),7.76(d,J=8.4Hz,2H),8.15(d,J=8.4Hz,2H).13C NMR(100MHz,CDCl3):δ52.58,116.21,117.82,129.94,132.09,133.75,165.26.Using the protocol of Example 1, the reaction was carried out at 80° C. for 3 h. Silica gel column chromatography, eluent: petroleum ether/ethyl acetate=10:1, the product was 73.9 mg of white solid, and the yield was 92%. 1 H NMR purity greater than 98%. 1 H NMR (400MHz, CDCl 3 ): δ3.97(s, 3H), 7.76(d, J=8.4Hz, 2H), 8.15(d, J=8.4Hz, 2H). 13 C NMR (100MHz, CDCl 3 ): δ52.58, 116.21, 117.82, 129.94, 132.09, 133.75, 165.26.

实施例13化合物(1m)Example 13 compound (1m)

采用实施例1方案,80℃下反应7h。硅胶柱层析,淋洗剂:石油醚/乙酸乙酯=12:1,产物为白色固体77.4mg,收率88%。1H NMR纯度大于98%。1H NMR(400MHz,CDCl3):δ1.43(t,J=6.8Hz,3H),4.43(q,J=6.8Hz,2H),7.60(t,J=8.0Hz,1H),7.84(d,J=7.6Hz,1H),8.28(d,J=8.0Hz,1H),8.33(s,1H).13C NMR(100MHz,CDCl3):δ14.09,61.64,112.72,117.79,129.28,131.60,133.06,133.48,135.72,164.43.Using the protocol of Example 1, the reaction was carried out at 80° C. for 7 h. Silica gel column chromatography, eluent: petroleum ether/ethyl acetate=12:1, the product was 77.4 mg of white solid, and the yield was 88%. 1 H NMR purity greater than 98%. 1 H NMR (400MHz, CDCl 3 ): δ1.43(t, J=6.8Hz, 3H), 4.43(q, J=6.8Hz, 2H), 7.60(t, J=8.0Hz, 1H), 7.84( d, J=7.6Hz, 1H), 8.28(d, J=8.0Hz, 1H), 8.33(s, 1H). 13 C NMR (100MHz, CDCl 3 ): δ14.09, 61.64, 112.72, 117.79, 129.28 ,131.60,133.06,133.48,135.72,164.43.

实施例14化合物(1n)Example 14 compound (1n)

采用实施例1方案,80℃下反应12h。硅胶柱层析,淋洗剂:石油醚/乙酸乙酯=3:1,产物为白色固体35.6mg,收率68%。1H NMR纯度大于98%。1H NMR(400MHz,CDCl3):δ7.46-7.49(m,1H),8.00(d,J=8.0Hz,1H),8.84(d,J=4.0Hz,1H),8.91(s,1H).13C NMR(100MHz,CDCl3):δ110.02,116.39,123.55,139.17,152.35,152.89.Using the protocol of Example 1, the reaction was carried out at 80° C. for 12 h. Silica gel column chromatography, eluent: petroleum ether/ethyl acetate=3:1, the product was 35.6 mg of white solid, and the yield was 68%. 1 H NMR purity greater than 98%. 1 H NMR (400MHz, CDCl 3 ): δ7.46-7.49(m, 1H), 8.00(d, J=8.0Hz, 1H), 8.84(d, J=4.0Hz, 1H), 8.91(s, 1H ). 13 C NMR (100MHz, CDCl 3 ): δ110.02, 116.39, 123.55, 139.17, 152.35, 152.89.

实施例15化合物(1o)Example 15 Compound (1o)

采用实施例2方案,80℃下反应12h。硅胶板层析,淋洗剂:石油醚/乙酸乙酯=2:1,产物为白色固体34.3mg,收率44%。1H NMR纯度大于98%。1H NMR(400MHz,CDCl3):δ7.57(dd,J=8.0,4.0Hz,1H),7.63(t,J=8.0Hz,1H),8.10(d,J=8.4Hz,1H),8.14(d,J=7.2Hz,1H),8.27(d,J=8.0Hz,1H),9.10-9.11(m,1H).13C NMR(100MHz,CDCl3):δ112.98,117.19,122.72,125.80,128.05,132.86,135.47,136.45,147.38,152.43.Using the scheme of Example 2, the reaction was carried out at 80° C. for 12 hours. Silica gel plate chromatography, eluent: petroleum ether/ethyl acetate=2:1, the product was 34.3 mg of white solid, and the yield was 44%. 1 H NMR purity greater than 98%. 1 H NMR (400MHz, CDCl 3 ): δ7.57 (dd, J = 8.0, 4.0Hz, 1H), 7.63 (t, J = 8.0Hz, 1H), 8.10 (d, J = 8.4Hz, 1H), 8.14(d, J=7.2Hz, 1H), 8.27(d, J=8.0Hz, 1H), 9.10-9.11(m, 1H). 13 C NMR(100MHz, CDCl 3 ): δ112.98, 117.19, 122.72, 125.80 ,128.05,132.86,135.47,136.45,147.38,152.43.

实施例16化合物(1p)Example 16 Compound (1p)

采用实施例1方案,80℃下反应12h。硅胶柱层析,淋洗剂:石油醚/乙酸乙酯=7:1到5:1,产物为白色固体57.9mg,收率41%。1H NMR纯度大于98%。1H NMR(400MHz,CDCl3,Me4Si):δ0.92(s,3H),1.48-1.65(m,6H),1.98-2.19(m,4H),2.40-2.41(m,2H),2.52(dd,J=18.8,9.2Hz,1H),2.93-2.96(m,2H),7.38–7.43(m,2H).13C NMR(100MHz,CDCl3,Me4Si):δ13.65,21.41,25.28,25.82,28.83,31.31,35.65,37.42,44.40,47.67,50.29,109.41,119.04,126.09,129.17,132.38,137.79,145.25,220.19.Using the protocol of Example 1, the reaction was carried out at 80° C. for 12 h. Silica gel column chromatography, eluent: petroleum ether/ethyl acetate=7:1 to 5:1, the product was 57.9 mg of white solid, and the yield was 41%. 1 H NMR purity greater than 98%. 1 H NMR (400MHz, CDCl 3 , Me 4 Si): δ0.92(s, 3H), 1.48-1.65(m, 6H), 1.98-2.19(m, 4H), 2.40-2.41(m, 2H), 2.52(dd,J=18.8,9.2Hz,1H),2.93-2.96(m,2H),7.38–7.43(m,2H). 13 C NMR(100MHz,CDCl 3 ,Me 4 Si):δ13.65, 21.41, 25.28, 25.82, 28.83, 31.31, 35.65, 37.42, 44.40, 47.67, 50.29, 109.41, 119.04, 126.09, 129.17, 132.38, 137.79, 145.25, 220.19.

实施例17化合物(1q)Example 17 Compound (1q)

采用实施例1方案,50℃下反应8h。硅胶板层析,淋洗剂:石油醚/乙酸乙酯=35:1,产物为白色固体71.6mg,收率93%。1H NMR纯度大于98%。1H NMR(400MHz,CDCl3):δ7.54-7.64(m,3H),7.82-7.87(m,3H),8.15(s,1H).13C NMR(100MHz,CDCl3):δ109.12,119.11,126.11,127.49,127.88,128.22,128.89,129.01,132.01,133.94,134.42.Using the protocol of Example 1, the reaction was carried out at 50° C. for 8 h. Silica gel plate chromatography, eluent: petroleum ether/ethyl acetate=35:1, the product was 71.6 mg of white solid, and the yield was 93%. 1 H NMR purity greater than 98%. 1 H NMR(400MHz, CDCl 3 ):δ7.54-7.64(m,3H),7.82-7.87(m,3H),8.15(s,1H). 13 C NMR(100MHz,CDCl 3 ):δ109.12,119.11 ,126.11,127.49,127.88,128.22,128.89,129.01,132.01,133.94,134.42.

实施例18化合物(1r)Example 18 Compound (1r)

采用实施例1方案,50℃下反应6h。硅胶板层析,淋洗剂:石油醚/乙酸乙酯=35:1,产物为浅黄色液体70.9mg,收率93%。1H NMR纯度大于98%。1H NMR(400MHz,CDCl3,Me4Si):δ7.48(dd,J=7.6Hz,1H),7.58(dd,J=7.6Hz,1H),7.65(dd,J=7.6Hz,1H),7.87(d,J=8.4Hz,2H),8.03(d,J=8.4Hz,1H),78.29(d,J=8.4Hz,1H).13C NMR(100MHz,CDCl3,Me4Si):δ109.93,117.70,124.76,124.91,127.39,128.43,128.52,132.13,132.46,132.72,133.14.Using the protocol of Example 1, the reaction was carried out at 50° C. for 6 h. Silica gel plate chromatography, eluent: petroleum ether/ethyl acetate=35:1, the product was 70.9 mg of light yellow liquid, and the yield was 93%. 1 H NMR purity greater than 98%. 1 H NMR (400MHz, CDCl 3 , Me 4 Si): δ7.48(dd, J=7.6Hz, 1H), 7.58(dd, J=7.6Hz, 1H), 7.65(dd, J=7.6Hz, 1H ), 7.87(d, J=8.4Hz, 2H), 8.03(d, J=8.4Hz, 1H), 78.29(d, J=8.4Hz, 1H). 13 C NMR (100MHz, CDCl 3 , Me 4 Si ): δ109.93, 117.70, 124.76, 124.91, 127.39, 128.43, 128.52, 132.13, 132.46, 132.72, 133.14.

实施例19化合物(1s)Example 19 Compound (1s)

采用实施例1方案,80℃下反应9h。硅胶柱层析,淋洗剂:石油醚/乙酸乙酯=30:1,产物为白色固体66.3mg,收率74%。1H NMR纯度大于98%。1H NMR(400MHz,CDCl3):δ7.42-7.50(m,3H),7.57-7.59(m,2H),7.66(d,J=8.8Hz,2H),7.71(d,J=8.4Hz,2H).13C NMR(100MHz,CDCl3):δ110.78,118.87,127.13,127.63,128.58,129.03,132.50,139.04,145.54.Using the protocol of Example 1, the reaction was carried out at 80° C. for 9 h. Silica gel column chromatography, eluent: petroleum ether/ethyl acetate=30:1, the product was 66.3 mg of white solid, and the yield was 74%. 1 H NMR purity greater than 98%. 1 H NMR (400MHz, CDCl 3 ): δ7.42-7.50(m, 3H), 7.57-7.59(m, 2H), 7.66(d, J=8.8Hz, 2H), 7.71(d, J=8.4Hz ,2H). 13 C NMR (100MHz, CDCl 3 ): δ110.78, 118.87, 127.13, 127.63, 128.58, 129.03, 132.50, 139.04, 145.54.

实施例20化合物(1t)Example 20 Compound (1t)

采用实施例1方案,80℃下反应12h。硅胶板层析,淋洗剂:石油醚/乙酸乙酯/二氯甲烷=100:3:1,产物为白色固体71.3mg,收率74%。1H NMR纯度大于98%。1H NMR(400MHz,CDCl3):δ2.40(s,3H),7.27(d,J=8.8Hz,2H),7.47(d,J=7.2Hz,2H),7.62-7.68(m,4H).13CNMR(100MHz,CDCl3):δ21.06,110.38,118.93,126.92,127.30,129.73,132.42,136.09,138.63,145.43.Using the protocol of Example 1, the reaction was carried out at 80° C. for 12 hours. Silica gel plate chromatography, eluent: petroleum ether/ethyl acetate/dichloromethane=100:3:1, the product was 71.3 mg of white solid, and the yield was 74%. 1 H NMR purity greater than 98%. 1 H NMR (400MHz, CDCl 3 ): δ2.40(s, 3H), 7.27(d, J=8.8Hz, 2H), 7.47(d, J=7.2Hz, 2H), 7.62-7.68(m, 4H ). 13 CNMR (100MHz, CDCl 3 ): δ21.06, 110.38, 118.93, 126.92, 127.30, 129.73, 132.42, 136.09, 138.63, 145.43.

实施例21化合物(1u)Example 21 compound (1u)

采用实施例1方案,80℃下反应12h。硅胶柱层析,淋洗剂:石油醚/乙酸乙酯=30:1,产物为白色固体86.7mg,收率83%。1H NMR纯度大于98%。1H NMR(400MHz,CDCl3):δ3.85(s,3H),6.95(d,J=8.0Hz,1H),7.09(s,1H),7.15(d,J=7.2Hz,2H),7.38(t,J=7.6Hz,1H),7.63-7.69(m,4H).13C NMR(100MHz,CDCl3):δ55.22,110.84,112.94,113.73,118.78,119.49,127.60,130.02,132.39,140.43,145.32,159.99.Using the protocol of Example 1, the reaction was carried out at 80° C. for 12 hours. Silica gel column chromatography, eluent: petroleum ether/ethyl acetate=30:1, the product was 86.7 mg of white solid, and the yield was 83%. 1 H NMR purity greater than 98%. 1 H NMR (400MHz, CDCl 3 ): δ3.85(s, 3H), 6.95(d, J=8.0Hz, 1H), 7.09(s, 1H), 7.15(d, J=7.2Hz, 2H), 7.38(t, J=7.6Hz, 1H), 7.63-7.69(m, 4H). 13 C NMR (100MHz, CDCl 3 ): δ55.22, 110.84, 112.94, 113.73, 118.78, 119.49, 127.60, 130.02, 132.39, 140.43 ,145.32,159.99.

实施例22化合物(1v)Example 22 compound (1v)

采用实施例1方案,80℃下反应12h。硅胶柱层析,淋洗剂:石油醚/乙酸乙酯=30:1,产物为白色固体78.9mg,收率80%。1H NMR纯度大于98%。1H NMR(400MHz,CDCl3):δ7.14-7.18(m,2H),7.54-7.57(m,2H),7.63(d,J=8.0Hz,2H),7.70(d,J=7.6Hz,2H).13C NMR(100MHz,CDCl3):δ110.81,115.98(2JC-F=21.5Hz),118.71,127.43,128.84(3JC-F=8.2Hz),132.51,135.15(4JC-F=3.7Hz),144.44,163.05(1JC-F=246.9Hz).19F NMR(376.1MHz,CDCl3)δ-113.13.Using the protocol of Example 1, the reaction was carried out at 80° C. for 12 h. Silica gel column chromatography, eluent: petroleum ether/ethyl acetate=30:1, the product was 78.9 mg of white solid, and the yield was 80%. 1 H NMR purity greater than 98%. 1 H NMR (400MHz, CDCl 3 ): δ7.14-7.18(m, 2H), 7.54-7.57(m, 2H), 7.63(d, J=8.0Hz, 2H), 7.70(d, J=7.6Hz ,2H). 13 C NMR (100MHz, CDCl 3 ): δ110.81, 115.98( 2 J CF =21.5Hz), 118.71, 127.43, 128.84( 3 J CF =8.2Hz), 132.51, 135.15( 4 J CF =3.7Hz ), 144.44, 163.05 ( 1 J CF =246.9Hz). 19 F NMR (376.1MHz, CDCl 3 ) δ-113.13.

实施例23化合物(1w)Example 23 compound (1w)

采用实施例1方案,80℃下反应12h。硅胶柱层析,淋洗剂:石油醚/二氯甲烷/乙酸乙酯=10:1.5:1,产物为白色固体90.6mg,收率89%。1H NMR纯度大于98%。1H NMR(400MHz,CDCl3):δ7.71(d,J=7.6Hz,4H),7.79(d,J=7.6Hz,4H).13C NMR(100MHz,CDCl3):δ112.33,118.36,127.89,132.82,143.49.Using the protocol of Example 1, the reaction was carried out at 80° C. for 12 hours. Silica gel column chromatography, eluent: petroleum ether/dichloromethane/ethyl acetate=10:1.5:1, the product was 90.6 mg of white solid, and the yield was 89%. 1 H NMR purity greater than 98%. 1 H NMR (400MHz, CDCl 3 ): δ7.71 (d, J=7.6Hz, 4H), 7.79 (d, J=7.6Hz, 4H). 13 C NMR (100MHz, CDCl 3 ): δ112.33, 118.36, 127.89, 132.82, 143.49.

实施例24化合物(1x)Example 24 compound (1x)

采用实施例1方案,80℃下反应12h。硅胶柱层析,淋洗剂:石油醚/乙酸乙酯=30:1,产物为白色固体78.4mg,收率85%。1H NMR纯度大于98%。1H NMR(400MHz,CDCl3):δ7.40(d,J=13.2Hz,2H),7.55(s,1H),7.65(m,4H).13C NMR(100MHz,CDCl3):δ110.29,118.83,122.51,125.78,126.67,127.03,132.54,139.82,140.16.Using the protocol of Example 1, the reaction was carried out at 80° C. for 12 hours. Silica gel column chromatography, eluent: petroleum ether/ethyl acetate=30:1, the product was 78.4 mg of white solid, and the yield was 85%. 1 H NMR purity greater than 98%. 1 H NMR (400MHz, CDCl 3 ): δ7.40 (d, J=13.2Hz, 2H), 7.55 (s, 1H), 7.65 (m, 4H). 13 C NMR (100MHz, CDCl 3 ): δ110. 29, 118.83, 122.51, 125.78, 126.67, 127.03, 132.54, 139.82, 140.16.

实施例25化合物(2a)Example 25 Compound (2a)

采用实施例1方案,80℃下反应12h。硅胶板层析,淋洗剂:石油醚/乙酸乙酯=20:1,产物为白色固体50.3mg,收率65%。1H NMR纯度大于98%。1H NMR(400MHz,CDCl3):δ2.49(t,J=13.2,4.8Hz,2H),2.84(t,J=8.4Hz,2H),6.87(t,J=4.8Hz,1H),7.13-7.15(m,1H),7.23-7.29(m,2H),7.43-7.45(m,1H).13C NMR(100MHz,CDCl3):δ23.63,25.96,114.29,117.04,124.64,127.12,127.87,128.59,129.04,134.09,143.81.Using the scheme of Example 1, react at 80°C for 12h. Silica gel plate chromatography, eluent: petroleum ether/ethyl acetate=20:1, the product was 50.3 mg of white solid, and the yield was 65%. 1 H NMR purity greater than 98%. 1 H NMR (400MHz, CDCl 3 ): δ2.49(t, J=13.2, 4.8Hz, 2H), 2.84(t, J=8.4Hz, 2H), 6.87(t, J=4.8Hz, 1H), 7.13-7.15(m,1H),7.23-7.29(m,2H),7.43-7.45(m,1H). 13 C NMR(100MHz,CDCl 3 ):δ23.63,25.96,114.29,117.04,124.64,127.12 ,127.87,128.59,129.04,134.09,143.81.

实施例26化合物(2b)Example 26 Compound (2b)

采用实施例1方案,80℃下反应8h。硅胶板层析,淋洗剂:石油醚/乙酸乙酯=20:1,产物为白色固体70.5mg,收率91%。1H NMR纯度大于98%。1H NMR(400MHz,CDCl3):δ2.52(t,J=8.4Hz,2H),2.88(t,J=8.4Hz,2H),7.12-7.16(m,3H),7.20-7.29(m,2H).13C NMR(100MHz,CDCl3):δ24.52,26.52,109.47,119.54,126.99,127.86,130.14,131.01,135.26,141.54.Using the protocol of Example 1, the reaction was carried out at 80° C. for 8 h. Silica gel plate chromatography, eluent: petroleum ether/ethyl acetate=20:1, the product was 70.5 mg of white solid, and the yield was 91%. 1 H NMR purity greater than 98%. 1 H NMR (400MHz, CDCl 3 ): δ2.52(t, J=8.4Hz, 2H), 2.88(t, J=8.4Hz, 2H), 7.12-7.16(m, 3H), 7.20-7.29(m ,2H). 13 C NMR (100MHz, CDCl 3 ): δ24.52, 26.52, 109.47, 119.54, 126.99, 127.86, 130.14, 131.01, 135.26, 141.54.

实施例27化合物(2c)Example 27 Compound (2c)

采用实施例1方案,80℃下反应7h。硅胶板层析,淋洗剂:石油醚/乙酸乙酯=15:1,产物为白色固体78.9mg,收率86%。1H NMR纯度大于98%。M.p.:59.3-61.2℃.1H NMR(400MHz,CDCl3):δ6.14(s,1H),6.39(s,1H),7.43-7.44(m,2H),7.50-7.58(m,2H),7.85-7.87(m,2H),8.10(t,J=8.4Hz,2H).13C NMR(100MHz,CDCl3):δ118.33,122.01,124.09,125.13,126.42,126.90,127.04,128.60,130.02,130.09,131.62,133.49,134.69.IR(neat):3028,2211,1635,1601,1492,1452,1434,1417,1077,1027,976,945,926,834,761,699.HRMS(EI)for C13H13N[M]+:calcd 183.1048,found 183.1042.Using the protocol of Example 1, the reaction was carried out at 80° C. for 7 h. Silica gel plate chromatography, eluent: petroleum ether/ethyl acetate=15:1, the product was 78.9 mg of white solid, and the yield was 86%. 1 H NMR purity greater than 98%. Mp:59.3-61.2℃. 1 H NMR(400MHz,CDCl 3 ):δ6.14(s,1H),6.39(s,1H),7.43-7.44(m,2H),7.50-7.58(m,2H) ,7.85-7.87(m,2H),8.10(t,J=8.4Hz,2H). 13 C NMR(100MHz,CDCl 3 ):δ118.33,122.01,124.09,125.13,126.42,126.90,127.04,128.60,130.02, 130.09,131.62,133.49,134.69.IR(neat):3028,2211,1635,1601,1492,1452,1434,1417,1077,1027,976,945,926,834,761,699.HRMS(EI)for C 13 H + 13 N[M calcd 183.1048, found 183.1042.

实施例28化合物(2d)Example 28 Compound (2d)

采用实施例1方案,80℃下反应7h。硅胶板层析,淋洗剂:石油醚/乙酸乙酯=30:1,产物为白色固体68.0mg,收率76%。1H NMR纯度大于98%。1H NMR(400MHz,CDCl3):δ1.76-1.83(m,1H),1.98-2.03(m,1H),2.23-2.33(m,1H),2.35-2.39(m,2H),2.46-2.52(m,1H),2.79-2.80(m,1H),6.69-6.70(m,1H),7.17-7.25(m,3H),7.32(t,J=7.6Hz,2H).13C NMR(100MHz,CDCl3):δ27.08,28.47,33.41,38.18,112.15,119.40,126.53,126.57,128.54,144.50,144.82.IR(neat):3057,2226,1590,1508,1402,1340,1252,1200,944,859,802,774,658,660.HRMS(ESI)calcd for C13H10N[M+H]+:180.0808,found 180.0808.Using the protocol of Example 1, the reaction was carried out at 80° C. for 7 h. Silica gel plate chromatography, eluent: petroleum ether/ethyl acetate=30:1, the product was 68.0 mg of white solid, and the yield was 76%. 1 H NMR purity greater than 98%. 1 H NMR (400MHz, CDCl 3 ): δ1.76-1.83(m,1H),1.98-2.03(m,1H),2.23-2.33(m,1H),2.35-2.39(m,2H),2.46- 2.52 (m, 1H), 2.79-2.80 (m, 1H), 6.69-6.70 (m, 1H), 7.17-7.25 (m, 3H), 7.32 (t, J=7.6Hz, 2H). 13 C NMR ( 100MHz, CDCl 3 ):δ27.08,28.47,33.41,38.18,112.15,119.40,126.53,126.57,128.54,144.50,144.82.IR(neat):3057,2226,1590,1508,1402,1340,12052 ,944,859,802,774,658,660.HRMS(ESI)calcd for C 13 H 10 N[M+H] + :180.0808,found 180.0808.

实施例29化合物(2e)Example 29 Compound (2e)

采用实施例1方案,80℃下反应7h。硅胶板层析,淋洗剂:石油醚/乙酸乙酯=20:1,产物为白色固体99.2mg,收率90%(Z:E=3.2:1)。1H NMR纯度大于98%。1H NMR(400MHz,CDCl3):δ3.66(s,2H),3.78(s,0.63H),6.94(s,1H),7.24-7.38(m,11H),7.69-7.71(m,2H).13C NMR(100MHz,CDCl3):δ35.33,42.01,110.56,113.83,118.58,120.16,127.10,127.21,128.20,128.54,128.67,128.70,128.75,128.77,128.80,128.84,129.44,129.99,133.39,133.54,136.24,136.32,143.92,145.11.Using the protocol of Example 1, the reaction was carried out at 80° C. for 7 h. Silica gel plate chromatography, eluent: petroleum ether/ethyl acetate=20:1, the product was 99.2 mg of white solid, and the yield was 90% (Z:E=3.2:1). 1 H NMR purity greater than 98%. 1 H NMR (400MHz, CDCl 3 ): δ3.66(s,2H),3.78(s,0.63H),6.94(s,1H),7.24-7.38(m,11H),7.69-7.71(m,2H ). 13 C NMR (100MHz, CDCl 3 ): δ35.33, 42.01, 110.56, 113.83, 118.58, 120.16, 127.10, 127.21, 128.20, 128.54, 128.67, 128.70, 128.75, 128.77, 1128.89, 4, 133.39, 133.54, 136.24, 136.32, 143.92, 145.11.

实施例30化合物(1a)Example 30 Compound (1a)

采用实施例1方案,底物改为4-acetylphenyl 4-methylbenzenesulfonate(145.2mg,0.5mmol)。80℃下反应12h。硅胶板层析,淋洗剂:石油醚/乙酸乙酯=5:1,产物为白色固体69.0mg,收率95%。1H NMR纯度大于98%。Using the protocol of Example 1, the substrate was changed to 4-acetylphenyl 4-methylbenzenesulfonate (145.2 mg, 0.5 mmol). Reaction at 80°C for 12h. Silica gel plate chromatography, eluent: petroleum ether/ethyl acetate=5:1, the product was 69.0 mg of white solid, and the yield was 95%. 1 H NMR purity greater than 98%.

实施例31化合物(1a)Example 31 Compound (1a)

采用实施例1方案,底物改为4-acetylphenyl trifluoromethanesulfonate(134.1mg,0.5mmol)。80℃下反应12h。硅胶板层析,淋洗剂:石油醚/乙酸乙酯=5:1,产物为白色固体67.2mg,收率93%。1H NMR纯度大于98%。Using the protocol of Example 1, the substrate was changed to 4-acetylphenyl trifluoromethanesulfonate (134.1 mg, 0.5 mmol). Reaction at 80°C for 12h. Silica gel plate chromatography, eluent: petroleum ether/ethyl acetate=5:1, the product was 67.2 mg of white solid, and the yield was 93%. 1 H NMR purity greater than 98%.

实施例32化合物(1a)Example 32 Compound (1a)

采用实施例2方案,底物改为4-acetylphenyl dimethylsulfamate(121.6mg,0.5mmol)。100℃下反应9h。硅胶板层析,淋洗剂:石油醚/乙酸乙酯=6:1,产物为白色固体45.5mg,收率63%。1H NMR纯度大于98%。Using the protocol of Example 2, the substrate was changed to 4-acetylphenyl dimethylsulfamate (121.6 mg, 0.5 mmol). Reaction at 100°C for 9h. Silica gel plate chromatography, eluent: petroleum ether/ethyl acetate=6:1, the product was 45.5 mg of white solid, and the yield was 63%. 1 H NMR purity greater than 98%.

实施例32化合物(1b)Example 32 Compound (1b)

采用实施例2方案,底物改为4-methoxyphenyl sulfurofluoridate(103.1mg,0.5mmol)(121.6mg,0.5mmol)。80℃下反应12h。硅胶板层析,淋洗剂:石油醚/乙酸乙酯=12:1,产物为白色固体51.1mg,收率77%。1H NMR纯度大于98%。Using the protocol of Example 2, the substrate was changed to 4-methoxyphenyl sulfurofluoridate (103.1 mg, 0.5 mmol) (121.6 mg, 0.5 mmol). Reaction at 80°C for 12h. Silica gel plate chromatography, eluent: petroleum ether/ethyl acetate=12:1, the product was 51.1 mg of white solid, and the yield was 77%. 1 H NMR purity greater than 98%.

实施例33化合物(1k)Example 33 Compound (1k)

在充满N2的手套箱中,向具有封口塞的小瓶中依次加入NiCl2·6H2O(11.9mg,0.05mmol),dppf(33.3mg,0.06mmol),Zinc(13.1mg,0.2mmol),Zn(CN)2(93.9mg,0.8mmol),DMAP(183.3mg,1.50mmol),4-chlorophenyl sulfurofluoridate(105.3mg,0.5mmol)和CH3CN(5mL)。盖好盖子后移出手套箱,直接置于80℃油浴中加热反应,12h后冷至室温,TLC检测后硅胶过滤,乙酸乙酯洗,浓缩后柱层析。硅胶板层析,淋洗剂:石油醚/二氯甲烷=3:2到1:1,产物为白色固体58.7mg,收率92%。1H NMR纯度大于98%。In a glove box filled with N 2 , NiCl 2 6H 2 O (11.9 mg, 0.05 mmol), dppf (33.3 mg, 0.06 mmol), Zinc (13.1 mg, 0.2 mmol), Zn(CN) 2 (93.9 mg, 0.8 mmol), DMAP (183.3 mg, 1.50 mmol), 4-chlorophenyl sulfurofluoridate (105.3 mg, 0.5 mmol) and CH 3 CN (5 mL). After covering the lid, remove it from the glove box, place it directly in an oil bath at 80°C for heating reaction, cool to room temperature after 12 hours, filter on silica gel after TLC detection, wash with ethyl acetate, concentrate and perform column chromatography. Silica gel plate chromatography, eluent: petroleum ether/dichloromethane=3:2 to 1:1, the product was 58.7 mg of white solid, and the yield was 92%. 1 H NMR purity greater than 98%.

实施例34化合物(1a)Example 34 Compound (1a)

在充满N2的手套箱中,向具有封口塞的小瓶中依次加入NiCl2·6H2O(5.9mg,0.025mmol),dppf(16.6mg,0.03mmol),Zn(6.5mg,0.1mmol),Zn(CN)2(47.0mg,0.4mmol),DMAP(61.1mg,0.5mmol),4-乙酰基苯基甲磺酸酯(107.1mg,0.5mmol),CH3CN(5mL)。盖好盖子后移出手套箱,直接置于80℃油浴中加热反应,12h后冷至室温,TLC检测后硅胶过滤,乙酸乙酯洗,浓缩后柱层析。淋洗剂:石油醚/乙酸乙酯=5:1,产物为白色固体64.0mg,收率88%,1H NMR纯度大于98%。In a glove box filled with N 2 , NiCl 2 6H 2 O (5.9 mg, 0.025 mmol), dppf (16.6 mg, 0.03 mmol), Zn (6.5 mg, 0.1 mmol), Zn(CN) 2 (47.0 mg, 0.4 mmol), DMAP (61.1 mg, 0.5 mmol), 4-acetylphenyl mesylate (107.1 mg, 0.5 mmol), CH 3 CN (5 mL). After covering the lid, remove it from the glove box, place it directly in an oil bath at 80°C for heating reaction, cool to room temperature after 12 hours, filter on silica gel after TLC detection, wash with ethyl acetate, concentrate and perform column chromatography. Eluent: petroleum ether/ethyl acetate=5:1, the product is 64.0 mg of white solid, the yield is 88%, and the 1 H NMR purity is greater than 98%.

实施例35化合物(1a)Example 35 Compound (1a)

采用实施例34方案,配体更改为dppb(12.8mg,0.03mmol)。80℃下反应12h。硅胶柱层析,淋洗剂:石油醚/乙酸乙酯=5:1,产物为白色固体64.8mg,收率89%,1H NMR纯度大于98%。Using the protocol of Example 34, the ligand was changed to dppb (12.8mg, 0.03mmol). Reaction at 80°C for 12h. Silica gel column chromatography, eluent: petroleum ether/ethyl acetate=5:1, the product was 64.8 mg of white solid, the yield was 89%, and the 1 H NMR purity was greater than 98%.

实施例36化合物(1a)Example 36 Compound (1a)

采用实施例34方案,配体更改为Xantphos(17.4mg,0.03mmol)。80℃下反应12h。硅胶柱层析,淋洗剂:石油醚/乙酸乙酯=5:1。产物为白色固体16.4mg,收率23%。1H NMR纯度大于98%。Using the protocol of Example 34, the ligand was changed to Xantphos (17.4mg, 0.03mmol). Reaction at 80°C for 12h. Silica gel column chromatography, eluent: petroleum ether/ethyl acetate=5:1. The product was white solid 16.4 mg, yield 23%. 1 H NMR purity greater than 98%.

实施例37化合物(1a)Example 37 Compound (1a)

采用实施例34方案,配体更改为DPEphos(16.2mg,0.03mmol)。80℃下反应12h。硅胶柱层析,淋洗剂:石油醚/乙酸乙酯=5:1。产物为白色固体43.3mg,收率60%。1H NMR纯度大于98%Using the protocol of Example 34, the ligand was changed to DPEphos (16.2 mg, 0.03 mmol). Reaction at 80°C for 12h. Silica gel column chromatography, eluent: petroleum ether/ethyl acetate=5:1. The product is 43.3mg of white solid, the yield is 60%. 1 H NMR purity greater than 98%

实施例38化合物(1a)Example 38 Compound (1a)

采用实施例34方案,配体更改为PMe2Ph(8.3mg,0.06mmol)。80℃下反应12h。硅胶柱层析,淋洗剂:石油醚/乙酸乙酯=5:1。产物为白色固体52.9mg,收率73%。1H NMR纯度大于98%。Using the protocol of Example 34, the ligand was changed to PMe 2 Ph (8.3 mg, 0.06 mmol). Reaction at 80°C for 12h. Silica gel column chromatography, eluent: petroleum ether/ethyl acetate=5:1. The product was 52.9 mg of white solid, and the yield was 73%. 1 H NMR purity greater than 98%.

实施例39化合物(1a)Example 39 Compound (1a)

采用实施例34方案,配体更改为PMePh2(12.0mg,0.06mmol)。80℃下反应12h。硅胶柱层析,淋洗剂:石油醚/乙酸乙酯=5:1。产物为白色固体52.9mg,收率73%。1H NMR纯度大于98%。Using the protocol of Example 34, the ligand was changed to PMePh 2 (12.0 mg, 0.06 mmol). Reaction at 80°C for 12h. Silica gel column chromatography, eluent: petroleum ether/ethyl acetate=5:1. The product was 52.9 mg of white solid, and the yield was 73%. 1 H NMR purity greater than 98%.

实施例40化合物(1a)Example 40 Compound (1a)

采用实施例34方案,配体更改为PPh3(12.0mg,0.06mmol)。80℃下反应12h。硅胶柱层析,淋洗剂:石油醚/乙酸乙酯=5:1。产物为白色固体13.2mg,收率18%。1H NMR纯度大于98%。Using the protocol of Example 34, the ligand was changed to PPh 3 (12.0 mg, 0.06 mmol). Reaction at 80°C for 12h. Silica gel column chromatography, eluent: petroleum ether/ethyl acetate=5:1. The product was white solid 13.2mg, yield 18%. 1 H NMR purity greater than 98%.

实施例41化合物(1a)Example 41 Compound (1a)

采用实施例34方案,催化剂更改为NiBr2·DME(7.7mg,0.06mmol)。80℃下反应12h。硅胶柱层析,淋洗剂:石油醚/乙酸乙酯=5:1。产物为白色固体63.1mg,收率87%。1HNMR纯度大于98%。Using the protocol of Example 34, the catalyst was changed to NiBr 2 ·DME (7.7 mg, 0.06 mmol). Reaction at 80°C for 12h. Silica gel column chromatography, eluent: petroleum ether/ethyl acetate=5:1. The product was 63.1 mg of white solid, and the yield was 87%. 1 HNMR purity greater than 98%.

实施例42化合物(1a)Example 42 Compound (1a)

采用实施例34方案,催化剂更改为NiI2(7.8mg,0.06mmol)。80℃下反应12h。硅胶柱层析,淋洗剂:石油醚/乙酸乙酯=5:1。产物为白色固体59.7mg,收率82%。1H NMR纯度大于98%Using the protocol of Example 34, the catalyst was changed to NiI 2 (7.8mg, 0.06mmol). Reaction at 80°C for 12h. Silica gel column chromatography, eluent: petroleum ether/ethyl acetate=5:1. The product was 59.7 mg of white solid, and the yield was 82%. 1 H NMR purity greater than 98%

实施例43化合物(1a)Example 43 Compound (1a)

采用实施例34方案,溶剂更改为DMA(5mL)。80℃下反应12h。硅胶柱层析,淋洗剂:石油醚/乙酸乙酯=5:1。产物为白色固体62.5mg,收率87%。1H NMR纯度大于98%Using the protocol of Example 34, the solvent was changed to DMA (5 mL). Reaction at 80°C for 12h. Silica gel column chromatography, eluent: petroleum ether/ethyl acetate=5:1. The product was 62.5 mg of white solid, and the yield was 87%. 1 H NMR purity greater than 98%

实施例44化合物(1a)Example 44 Compound (1a)

采用实施例34方案,溶剂更改为NMP(5mL)。80℃下反应12h。硅胶柱层析,淋洗剂:石油醚/乙酸乙酯=5:1。产物为白色固体42.4mg,收率58%。1H NMR纯度大于98%。Using the protocol of Example 34, the solvent was changed to NMP (5 mL). Reaction at 80°C for 12h. Silica gel column chromatography, eluent: petroleum ether/ethyl acetate=5:1. The product was 42.4 mg of white solid, and the yield was 58%. 1 H NMR purity greater than 98%.

实施例45化合物(1a)Example 45 Compound (1a)

采用实施例34方案,温度更改为60℃。60℃下反应12h。硅胶柱层析,淋洗剂:石油醚/乙酸乙酯=5:1。产物为白色固体61.9mg,收率85%。1H NMR纯度大于98%。Using the scheme of Example 34, the temperature was changed to 60°C. Reaction at 60°C for 12h. Silica gel column chromatography, eluent: petroleum ether/ethyl acetate=5:1. The product was 61.9 mg of white solid, and the yield was 85%. 1 H NMR purity greater than 98%.

实施例46化合物(1b)Example 46 Compound (1b)

在充满N2的手套箱中,向具有封口塞的小瓶中依次加入NiCl2·6H2O(11.9mg,0.05mmol),dppf(33.3mg,0.06mmol),Zn(13.1mg,0.2mmol),Zn(CN)2(47.0mg,0.4mmol),DMAP(91.6mg,0.75mmol),NaI(37.5mg,0.25mmol),4-甲氧基苯基甲磺酸酯(107.1mg,0.5mmol),DMF(5mL)。盖好盖子后移出手套箱,直接置于80℃油浴中加热反应,12h后冷至室温,TLC检测反应。反应结束后水淬灭,Et2O萃取三次,有机相水洗,饱和食盐水洗,合并水相,Et2O反萃取两次,合并有机相,无水硫酸镁干燥,过滤浓缩后柱层析。硅胶柱层析,淋洗剂:石油醚/乙酸乙酯=10:1,产物为白色固体43.2mg,收率65%,1H NMR纯度大于98%。In a glove box filled with N 2 , NiCl 2 6H 2 O (11.9mg, 0.05mmol), dppf (33.3mg, 0.06mmol), Zn (13.1mg, 0.2mmol), Zn(CN) 2 (47.0mg, 0.4mmol), DMAP (91.6mg, 0.75mmol), NaI (37.5mg, 0.25mmol), 4-methoxyphenyl mesylate (107.1mg, 0.5mmol), DMF (5 mL). After covering the lid, remove it from the glove box, place it directly in an 80°C oil bath for heating reaction, cool to room temperature after 12 hours, and detect the reaction by TLC. After the reaction, quenched with water, extracted three times with Et 2 O, washed the organic phase with water, washed with saturated brine, combined the aqueous phase, back-extracted twice with Et 2 O, combined the organic phase, dried over anhydrous magnesium sulfate, filtered and concentrated, and then column chromatography. Silica gel column chromatography, eluent: petroleum ether/ethyl acetate=10:1, the product was 43.2 mg of white solid, the yield was 65%, and the 1 H NMR purity was greater than 98%.

实施例47化合物(1b)Example 47 Compound (1b)

采用实施例46方案,添加剂更改为Et4NI(64.3mg,0.25mmol)。硅胶柱层析,淋洗剂:石油醚/乙酸乙酯=10:1,产物为白色固体45.9mg,收率70%。1H NMR纯度大于98%。Using the protocol of Example 46, the additive was changed to Et 4 NI (64.3 mg, 0.25 mmol). Silica gel column chromatography, eluent: petroleum ether/ethyl acetate=10:1, the product was 45.9 mg of white solid, and the yield was 70%. 1 H NMR purity greater than 98%.

Claims (13)

1. A preparation method of an aromatic nitrile compound shown as a formula I comprises the following steps: under the protection of inert gas, in a solvent and in the presence of a nickel complex, metal zinc and an additive, carrying out cross coupling reaction on an aryl or heteroaryl sulfonate compound shown as a formula II and a cyanation reagent as shown in the specification; wherein the additive is 4-dimethylamino pyridine, and the cyanation reagent is zinc cyanide;
in the aromatic nitrile compounds shown in the formula I and the aryl or heteroaryl sulfonate compounds shown in the formula II,
n is selected from any integer between 0- [ M-1], wherein M represents the maximum number of substitutions on ring α;
R1identical or different, each independently selected from halogen, C1-C6Linear OR branched alkoxy, -CN, -C (═ O) ORa、-NRbRc、-C(=O)Rd、-C(=O)NReRf、RgSubstituted C3-C10Or R is aryl or heteroaryl, orhSubstituted C1-C6Linear or branched alkyl of (a); wherein R isa、Rb、Rc、Rd、Re、Rf、RgAnd RhEach independently selected from-H, halogen, -OH, -CN, C1-C4A straight or branched alkoxy group of (A), and C1-C4One or more of linear or branched alkyl groups of (a);
or, any two adjacently substituted R1Together with the atoms of ring α to which they are each attached, form a carbocyclic or carbocyclic heterocyclic ring fused to ring α, said carbocyclic or carbocyclic heterocyclic ring being a 3-10 membered ring, said carbocyclic or carbocyclic heterocyclic ring containing 1-4 heteroatoms selected from O, N and S;
-OS(=O)2r in R is selected from halogen and C1-C6Straight or branched alkyl of (2), C1-C6Or R is a linear or branched haloalkyl groupiSubstituted phenyl; wherein R isiSelected from halogen, C1-C6Straight or branched alkyl of, or-NRjRkWherein R isjAnd RkEach independently selected from C1-C4Linear or branched alkyl of (a);
ring α is an aromatic or heteroaromatic ring, wherein when ring α is an aromatic ring, the aromatic ring is any stable monocyclic or polycyclic carbocyclic ring of up to 6 atoms in each ring, at least one ring of the polycyclic rings being aromatic, and when ring α is an aromatic ring, the aromatic ring is optionally substituted with one or more substituents selected from the group consisting of alkyl, aryl, heteroaryl, and optionally substitutedWhen the aromatic ring is polycyclic and a non-aromatic ring is present, -OS (═ O)2Wherein when ring α is an aromatic heterocycle, the aromatic heterocycle is any stable monocyclic or polycyclic ring of up to 6 atoms in each ring, at least one ring of the polycyclic ring is aromatic and contains 1 to 4 heteroatoms selected from O, N and S, and when the aromatic heterocycle is polycyclic and wherein a non-aromatic ring is present or contains no heteroatoms, -OS (═ O)2The attachment of R and-CN to each other is via a "heteroatom-containing aromatic ring".
2. The method according to claim 1, wherein,
n is 0, 1 or 2;
and/or when Ra、Rb、Rc、Rd、Re、Rf、RgAnd RhWhen any one of the halogen is fluorine, chlorine, bromine or iodine;
and/or when Ra、Rb、Rc、Rd、Re、Rf、RgAnd RhAny one of them is C1-C4Said C is a straight or branched alkoxy group of1-C4Is C1-C3Is preferably methoxy, ethoxy, propoxy or isopropoxy;
and/or when Ra、Rb、Rc、Rd、Re、Rf、RgAnd RhAny one of them is C1-C4When the alkyl group is a straight or branched alkyl group, said C1-C4Is C1-C3Preferably methyl, ethyl, propyl or isopropyl;
and/or when R1When the halogen is fluorine, chlorine, bromine or iodine;
and/or when R1Is C1-C6Said C is a straight or branched alkoxy group of1-C6Is C1-C3Is preferably methoxy, ethoxy, propoxy or isopropoxy;
and/or when R1is-C (═ O) ORaWhen R isaIs C1-C4Preferably methyl, ethyl, propyl or isopropyl;
and/or when R1is-NRbRcWhen R isbAnd RcEach independently is C1-C4Preferably methyl, ethyl, propyl or isopropyl;
and/or when R1is-C (═ O) RdWhen R isdIs C1-C4Preferably methyl, ethyl, propyl or isopropyl;
and/or when R1is-C (═ O) NReRfWhen R iseAnd RfEach independently is C1-C4Preferably methyl, ethyl, propyl or isopropyl;
and/or when R1Is RgSubstituted C3-C10Aryl or heteroaryl of (A), said C3-C10Aryl or heteroaryl of (a) is phenyl or thienyl;
and/or when R1Is RhSubstituted C1-C6When the alkyl group is a straight or branched alkyl group, said C1-C6Is C1-C3Preferably methyl, ethyl, propyl or isopropyl;
and/or, when any two of adjacently substituted R are1When the atoms of ring α to which each is attached form a carbocyclic or carbocyclic ring fused to ring α, said carbocyclic or carbocyclic ring is a 3-5 membered ring and said carbocyclic ring contains 1 or 2 heteroatoms selected from O, N and S;
and/or, when n is 1, R1Preferably selected from methyl, n-butyl, methoxyA group, amino, acetyl, methoxycarbonyl, ethoxycarbonyl, cyano or phenyl; when n is 2, R1Identical or different, each of which is independently preferably selected from methyl or methoxy; or two R1Taken together with the atom on ring α to which each is attached to form a dioxolanyl group;
and/or when RiWhen the halogen is fluorine, chlorine, bromine or iodine;
and/or when RiIs C1-C6When the alkyl group is a straight or branched alkyl group, said C1-C6Is C1-C3Preferably methyl, ethyl, propyl or isopropyl;
and/or when Riis-NRjRkWhen said is-NRjRkIn RjAnd RkEach independently is methyl, ethyl, propyl or isopropyl;
and/or, when R is halogen, said halogen is fluorine, chlorine, bromine or iodine;
and/or, when R is C1-C6When the alkyl group is a straight or branched alkyl group, said C1-C6Is C1-C3Preferably methyl, ethyl, propyl or isopropyl;
and/or, when R is C1-C6When said alkyl is a straight or branched chain haloalkyl, said C1-C6Is C1-C3Preferably trifluoromethyl, is used as the straight or branched chain haloalkyl group of (1).
3. The method according to claim 1, wherein,
said-OS (═ O)2R is fluorosulfonyl, trifluoromethanesulfonyl, methanesulfonyl, p-tolylsulfonyl or aminosulfonyl;
and/or the aromatic ring is a monocyclic aromatic ring or a bicyclic fused ring aromatic ring, preferably a benzene ring or a naphthalene ring;
and/or the aromatic heterocycle is a monocyclic pyridine ring or a bicyclic quinoline ring.
4. The method according to claim 1, wherein the aryl or heteroaryl sulfonate compound of formula II and the aromatic nitrile compound of formula I are any pair of compounds selected from the group consisting of:
5. the method according to claim 1, wherein in the method for producing an aromatic nitrile compound represented by the formula I,
the inert protective gas is one or more of nitrogen, helium, argon and neon;
and/or the molar ratio of the aryl or heteroaryl sulfonate compound shown as the formula II to DMAP is 1:0.1-1:10, preferably 1:1-1: 1.5;
and/or the molar ratio of the aryl or heteroaryl sulfonate compound shown as the formula II to the metal zinc is 1:0.01-1:10, more preferably 1:0.1-1:1, and further preferably 1:0.2-1: 0.4;
and/or, the nickel complex is NiBr2(PPh3)2And/or NiCl2(dppf);
And/or the molar ratio of the aryl or heteroaryl sulfonate compound shown as the formula II to the nickel complex is 1:0.01-1:1, more preferably 1:0.02-1:0.50, and further preferably 1:0.05-1: 0.10;
and/or the molar ratio of the aryl or heteroaryl sulfonate compound shown as the formula II to the cyanation reagent is 1:0.1-1:10, more preferably 1:0.5-1:2, further preferably 1:0.6-1:1.2, or preferably 1: 0.8;
and/or the solvent is one or more of aromatic hydrocarbon solvent, ether solvent, halogenated hydrocarbon solvent, nitrile solvent, amide solvent and sulfoxide solvent; the aromatic hydrocarbon solvent is preferably one or more of benzene, toluene and xylene; the ether solvent is preferably one or more of diethyl ether, 1, 4-dioxane and tetrahydrofuran; the halogenated hydrocarbon solvent is preferably a chlorinated hydrocarbon solvent; the chlorinated hydrocarbon solvent is preferably one or more of dichloromethane, dichloroethane and chloroform; the nitrile solvent is preferably acetonitrile; the amide solvent is preferably one or more of N, N-dimethylformamide, N-Dimethylacetamide (DMA) and hexamethylphosphoramide; the sulfoxide solvent is preferably dimethyl sulfoxide; the solvent is more preferably one or more of acetonitrile, N-dimethylformamide and N, N-dimethylacetamide;
and/or the molar volume ratio of the aryl or heteroaryl sulfonate compound shown in the formula II to the solvent is 0.01mmol/mL-1mmol/mL, preferably 0.1mmol/mL-0.5 mmol/mL;
and/or the reaction temperature of the cross-coupling reaction is-100 ℃ to 500 ℃, preferably 0 ℃ to 150 ℃, more preferably 50 ℃ to 100 ℃, and further preferably 60 ℃ to 80 ℃;
and/or the reaction time of the cross-coupling reaction is 0.1-200h, preferably 3-12 h.
6. The method according to claim 1, wherein in the method for producing an aromatic nitrile compound represented by the formula I,
the reaction system also comprises other additives besides the additive DMAP, wherein the other additives are quaternary ammonium salt and/or inorganic salt; wherein, the quaternary ammonium salt is preferably tetraethyl ammonium iodide; the inorganic salt is preferably one or more of sodium iodide, potassium iodide and lithium iodide, and more preferably potassium iodide; when the reaction system further comprises quaternary ammonium salt and/or inorganic salt, the molar ratio of the aryl or heteroaryl sulfonate compound shown as the formula II to the quaternary ammonium salt and/or the inorganic salt is preferably 1:0.1-1:10, and more preferably 1:0.5-1: 1;
and/or the nickel complex is subjected to in-situ coordination in a reaction system by a nickel precursor catalyst and a suitable ligand thereof and then participates in the reaction; wherein the nickel precursor catalyst is selected from the group consisting of Ni (cod)2、NiCl2、NiBr2、NiI2、NiBr2(diglyme)、NiCl2(glyme)、NiBr2(DME)、NiF2And NiCl2·6H2One or more of O, preferably NiBr2(DME)、NiI2And NiCl2·6H2One or more of O; suitable ligands for the nickel precursor catalyst are selected from one or more of triphenylphosphine, triethylphosphine, tributylphosphine, tricyclohexylphosphine, bisdiphenylphosphinomethane, dimethylphenylphosphine, diphenylmethylphosphine, 1, 2-bis (diphenylphosphino) ethane, 1, 3-bis (diphenylphosphino) propane, 1, 4-bis (diphenylphosphino) butane, 1' -bis (diphenylphosphino) ferrocene, 9-dimethyl-4, 5-bisdiphenylphosphine xanthene, 4, 5-bis (di-tert-butylphosphino) -9, 9-dimethylxanthene and 3- (dicyclohexylphosphino) -1-methyl-2-phenyl-1H-indole, more preferably bisdiphenylphosphinomethane, diphenylmethylphosphine, 1, 2-bis (diphenylphosphino) ethane, tris (diphenylphosphino) methane, bis (diphenylphosphino) ethane, bis (diphenylphosphino) methane, bis (diphenylphosphino) ferrocene, bis (diphenylphosphino, One or more of 1, 3-bis (diphenylphosphino) propane, 1, 4-bis (diphenylphosphino) butane, 1 '-bis (diphenylphosphino) ferrocene and 9, 9-dimethyl-4, 5-bisdiphenylphosphinoanthracene, further preferably one or more of diphenylmethylphosphine, 1' -bis (diphenylphosphino) ferrocene and 9, 9-dimethyl-4, 5-bisdiphenylphosphinoanthracene; the molar ratio of the nickel precursor catalyst to the suitable ligand is preferably 1:1 to 1:10, more preferably 1:1 to 1:5, and even more preferably 1: 1.2.
7. A preparation method of alkenyl nitrile compounds shown in formula III comprises the following steps: under the protection of inert gas, under the condition of existence of a nickel complex, metal zinc and an additive, an alkenyl sulfonate compound shown as IV and a cyanation reagent are subjected to cross coupling reaction shown as follows; wherein the additive is 4-dimethylaminopyridine; the cyanation reagent is zinc cyanide;
in the alkenyl nitrile compounds shown in the formula III and the alkenyl sulfonate compounds shown in the formula IV,
R2、R3and R4Each independently selected from-H, - (CH)2)x-RmSubstituted C3-C10Or R is aryl or heteroaryl, ornSubstituted C1-C6Linear or branched alkyl of (a); wherein R ismAnd RnEach independently selected from-H, halogen, -OH, -CN, C1-C4Linear or branched alkoxy and C1-C4One or more of linear or branched alkyl groups of (a); x is selected from any integer between 0 and 4;
or, R2And R3Or R2And R4Together form a quilt RnA substituted 5-10 membered monocyclic or polycyclic carbocyclic or carbocyclic ring containing 1-4 heteroatoms selected from O, N and S; the 5-10 membered monocyclic or polycyclic carbocyclic or carbocyclic ring is a saturated or semi-saturated ring;
-OS(=O)2r in R is selected from halogen and C1-C6Straight or branched alkyl of (2), C1-C6Or R is a linear or branched haloalkyl groupiSubstituted phenyl; wherein R isiSelected from halogen, C1-C6Straight or branched alkyl of, or-NRjRkWherein R isjAnd RkEach independently selected from C1-C4Linear or branched alkyl.
8. The method according to claim 7, wherein,
x is 0, 1,2 or 3;
and/or when RmAnd RnWhen any one of the above is halogen, the halogen is preferably fluorine, chlorine, bromine or iodine;
and/or when RmAnd RnAny one of them is C1-C4Of a straight chain orWhen the alkoxy group is branched, said C1-C4Is C1-C3Is preferably methoxy, ethoxy, propoxy or isopropoxy;
and/or when RmAnd RnAny one of them is C1-C4When the alkyl group is a straight or branched alkyl group, said C1-C4Is C1-C3Preferably methyl, ethyl, propyl or isopropyl;
and/or when RiWhen the halogen is fluorine, chlorine, bromine or iodine;
and/or when RiIs C1-C6When the alkyl group is a straight or branched alkyl group, said C1-C6Is C1-C3Preferably methyl, ethyl, propyl or isopropyl;
and/or when Riis-NRjRkWhen said is-NRjRkIn RjAnd RkEach independently is methyl, ethyl, propyl or isopropyl;
and/or, when R is halogen, said halogen is fluorine, chlorine, bromine or iodine;
and/or, when R is C1-C6When the alkyl group is a straight or branched alkyl group, said C1-C6Is C1-C3Preferably methyl, ethyl, propyl or isopropyl;
and/or, when R is C1-C6When said alkyl is a straight or branched chain haloalkyl, said C1-C6Is C1-C3Preferably trifluoromethyl, is used as the straight or branched chain haloalkyl group of (1).
9. The method according to claim 7, wherein,
said-OS (═ O)2R is fluorosulfonyl, trifluoromethanesulfonyl or methylsulfonylAcyl, p-tolylsulfonyl or aminosulfonyl;
and/or, said- (CH)2)x-RmSubstituted C3-C10In the aryl or heteroaryl group of (a), said C3-C10Aryl or heteroaryl of (A) is C6-C10Aryl of (a), preferably phenyl or naphthyl;
and/or, said RnSubstituted C1-C6In the straight or branched alkyl group of (1), said C1-C6Is C1-C3Preferably methyl, ethyl, propyl or isopropyl;
and/or said 5-to 10-membered monocyclic or polycyclic carbocycle is preferably a monocyclic or bicyclic carbocycle, preferably cyclohexene or benzocycloalkene.
10. The method according to claim 7, wherein the alkenyl sulfonate compound of formula IV and the alkenyl nitrile compound of formula III are any pair of compounds selected from the group consisting of:
11. the method according to claim 7, wherein, in the method for producing an alkenylnitrile compound represented by the formula III,
the inert protective gas is one or more of nitrogen, helium, argon and neon;
and/or the molar ratio of the alkenyl sulfonate compound shown as the formula IV to DMAP is 1:0.1-1:10, preferably 1:1-1: 1.5;
and/or the molar ratio of the alkenyl sulfonate compound shown as the formula IV to the metal zinc is 1:0.01-1:10, preferably 1:0.1-1:1, and further preferably 1:0.2-1: 0.4;
and/or, the nickel complex is NiBr2(PPh3)2And/or NiCl2(dppf);
And/or the molar ratio of the alkenyl sulfonate compound shown as the formula IV to the nickel complex is 1:0.01-1:1, preferably 1:0.02-1:0.50, and further preferably 1:0.05-1: 0.10;
and/or the molar ratio of the alkenyl sulfonate compound shown as the formula IV to the cyanation reagent is 1:0.1-1:10, more preferably 1:0.5-1:2, further preferably 1:0.6-1:1.2, or preferably 1: 0.8;
and/or the solvent is one or more of aromatic hydrocarbon solvent, ether solvent, halogenated hydrocarbon solvent, nitrile solvent, amide solvent and sulfoxide solvent; the aromatic hydrocarbon solvent is preferably one or more of benzene, toluene and xylene; the ether solvent is preferably one or more of diethyl ether, 1, 4-dioxane and tetrahydrofuran; the halogenated hydrocarbon solvent is preferably a chlorinated hydrocarbon solvent; the chlorinated hydrocarbon solvent is preferably one or more of dichloromethane, dichloroethane and chloroform; the nitrile solvent is preferably acetonitrile; the amide solvent is preferably one or more of N, N-dimethylformamide, N-Dimethylacetamide (DMA) and hexamethylphosphoramide; the sulfoxide solvent is preferably dimethyl sulfoxide; the solvent is more preferably one or more of acetonitrile, N-dimethylformamide and N, N-dimethylacetamide;
and/or the mol volume ratio of the alkenyl sulfonate compound shown in the formula IV to the solvent is 0.01mmol/mL-1mmol/mL, preferably 0.1mmol/mL-0.5 mmol/mL;
and/or the reaction temperature of the cross-coupling reaction is-100 ℃ to 500 ℃, preferably 0 ℃ to 150 ℃, more preferably 50 ℃ to 100 ℃, and further preferably 60 ℃ to 80 ℃;
and/or the reaction time of the cross-coupling reaction is 0.1-200h, preferably 3-12 h.
12. The method according to claim 7, wherein, in the method for producing an alkenylnitrile compound represented by the formula III,
the reaction system also comprises other additives besides the additive DMAP, wherein the other additives are quaternary ammonium salt and/or inorganic salt; wherein, the quaternary ammonium salt is preferably tetraethyl ammonium iodide; the inorganic salt is preferably one or more of sodium iodide, potassium iodide and lithium iodide, and more preferably potassium iodide; when the reaction system further comprises quaternary ammonium salt and/or inorganic salt, the molar ratio of the alkenyl sulfonate compound shown as the formula IV to the quaternary ammonium salt and/or the inorganic salt is 1:0.1-1:10, preferably 1:0.5-1: 1;
and/or the nickel complex is subjected to in-situ coordination in a reaction system by a nickel precursor catalyst and a suitable ligand thereof and then participates in the reaction; wherein the nickel precursor catalyst is selected from the group consisting of Ni (cod)2、NiCl2、NiBr2、NiI2、NiBr2(diglyme)、NiCl2(glyme)、NiBr2(DME)、NiF2And NiCl2·6H2One or more of O, preferably NiBr2(DME)、NiI2And NiCl2·6H2One or more of O; suitable ligands for the nickel precursor catalyst are selected from one or more of triphenylphosphine, triethylphosphine, tributylphosphine, tricyclohexylphosphine, bisdiphenylphosphinomethane, dimethylphenylphosphine, diphenylmethylphosphine, 1, 2-bis (diphenylphosphino) ethane, 1, 3-bis (diphenylphosphino) propane, 1, 4-bis (diphenylphosphino) butane, 1' -bis (diphenylphosphino) ferrocene, 9-dimethyl-4, 5-bisdiphenylphosphine xanthene, 4, 5-bis (di-tert-butylphosphino) -9, 9-dimethylxanthene and 3- (dicyclohexylphosphino) -1-methyl-2-phenyl-1H-indole, more preferably bisdiphenylphosphinomethane, diphenylmethylphosphine, 1, 2-bis (diphenylphosphino) ethane, tris (diphenylphosphino) methane, bis (diphenylphosphino) ethane, bis (diphenylphosphino) methane, bis (diphenylphosphino) ferrocene, bis (diphenylphosphino, One or more of 1, 3-bis (diphenylphosphino) propane, 1, 4-bis (diphenylphosphino) butane, 1 '-bis (diphenylphosphino) ferrocene and 9, 9-dimethyl-4, 5-bisdiphenylphosphinoanthracene, further preferably one or more of diphenylmethylphosphine, 1' -bis (diphenylphosphino) ferrocene and 9, 9-dimethyl-4, 5-bisdiphenylphosphinoanthracene; of said nickel precursor catalyst with said ligandThe molar ratio is preferably 1:1 to 1:10, more preferably 1:1 to 1:5, and still more preferably 1: 1.2.
13. An aromatic or alkenyl nitrile compound represented by the following structure:
CN201810113897.7A 2018-02-05 2018-02-05 Preparation method of aromatic nitrile or alkenyl nitrile compound Active CN110117237B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810113897.7A CN110117237B (en) 2018-02-05 2018-02-05 Preparation method of aromatic nitrile or alkenyl nitrile compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810113897.7A CN110117237B (en) 2018-02-05 2018-02-05 Preparation method of aromatic nitrile or alkenyl nitrile compound

Publications (2)

Publication Number Publication Date
CN110117237A true CN110117237A (en) 2019-08-13
CN110117237B CN110117237B (en) 2024-02-02

Family

ID=67519299

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810113897.7A Active CN110117237B (en) 2018-02-05 2018-02-05 Preparation method of aromatic nitrile or alkenyl nitrile compound

Country Status (1)

Country Link
CN (1) CN110117237B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111187396A (en) * 2020-01-07 2020-05-22 复旦大学 Method for synthesizing linear polyacetylene substituted by different side groups through Heck coupling reaction
CN115490613A (en) * 2022-09-05 2022-12-20 浙江工业大学 Preparation method of aromatic nitrile compound
CN116332794A (en) * 2021-12-24 2023-06-27 上海合全药物研发有限公司 Preparation method of aryl nitrile compound
CN116354852A (en) * 2023-03-20 2023-06-30 南京理工大学 Strong pi electron delocalized alpha, beta-unsaturated nitrile and preparation method thereof

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001240584A (en) * 2000-03-02 2001-09-04 Chisso Corp A new method for producing acrylonitrile derivatives
CN101190858A (en) * 2006-11-29 2008-06-04 赛拓有限责任公司 Method for catalytic manufacture of aromatic or heteroaromatic nitriles
WO2008102749A1 (en) * 2007-02-20 2008-08-28 Takeda Pharmaceutical Company Limited Heterocyclic compound
CN101300247A (en) * 2005-10-27 2008-11-05 帝人制药株式会社 3-hydroxymethylbenzo[b]thiophene derivative and method for producing same
CN101300209A (en) * 2005-09-12 2008-11-05 赛拓有限责任公司 Nickel or iron catalysed carbon-carbon coupling reaction of arylenes, alkenes and alkines
WO2009042694A1 (en) * 2007-09-24 2009-04-02 Comentis, Inc. (3-hydroxy-4-amino-butan-2-yl) -3- (2-thiazol-2-yl-pyrrolidine-1-carbonyl) benzamide derivatives and related compounds as beta-secretase inhibitors for treating
CN101855202A (en) * 2007-11-08 2010-10-06 纳幕尔杜邦公司 Process for preparing 2-amino-5-cyanobenzoic acid derivatives
CN102946882A (en) * 2010-02-02 2013-02-27 格斯有限公司 Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators
CN103842335A (en) * 2011-09-30 2014-06-04 罗地亚经营管理公司 Method for producing nitrile compounds from ethylenically unsaturated compounds
WO2014142307A1 (en) * 2013-03-15 2014-09-18 公益財団法人相模中央化学研究所 Polycyclic pyrazolinone derivative and herbicide comprising same as effective component thereof
WO2016102633A1 (en) * 2014-12-23 2016-06-30 Genfit Heterocyclic derivatives as rorgamma modulators
CN106111132A (en) * 2016-06-17 2016-11-16 南京理工大学 A kind of Pd Zn bimetallic catalyst for preparing aryl cyanides
CN106243033A (en) * 2016-08-03 2016-12-21 凯莱英医药集团(天津)股份有限公司 The preparation method of aromatic nitrile compounds

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001240584A (en) * 2000-03-02 2001-09-04 Chisso Corp A new method for producing acrylonitrile derivatives
CN101300209A (en) * 2005-09-12 2008-11-05 赛拓有限责任公司 Nickel or iron catalysed carbon-carbon coupling reaction of arylenes, alkenes and alkines
CN101300247A (en) * 2005-10-27 2008-11-05 帝人制药株式会社 3-hydroxymethylbenzo[b]thiophene derivative and method for producing same
CN101190858A (en) * 2006-11-29 2008-06-04 赛拓有限责任公司 Method for catalytic manufacture of aromatic or heteroaromatic nitriles
WO2008102749A1 (en) * 2007-02-20 2008-08-28 Takeda Pharmaceutical Company Limited Heterocyclic compound
WO2009042694A1 (en) * 2007-09-24 2009-04-02 Comentis, Inc. (3-hydroxy-4-amino-butan-2-yl) -3- (2-thiazol-2-yl-pyrrolidine-1-carbonyl) benzamide derivatives and related compounds as beta-secretase inhibitors for treating
CN101855202A (en) * 2007-11-08 2010-10-06 纳幕尔杜邦公司 Process for preparing 2-amino-5-cyanobenzoic acid derivatives
CN102946882A (en) * 2010-02-02 2013-02-27 格斯有限公司 Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators
CN103842335A (en) * 2011-09-30 2014-06-04 罗地亚经营管理公司 Method for producing nitrile compounds from ethylenically unsaturated compounds
WO2014142307A1 (en) * 2013-03-15 2014-09-18 公益財団法人相模中央化学研究所 Polycyclic pyrazolinone derivative and herbicide comprising same as effective component thereof
WO2016102633A1 (en) * 2014-12-23 2016-06-30 Genfit Heterocyclic derivatives as rorgamma modulators
CN106111132A (en) * 2016-06-17 2016-11-16 南京理工大学 A kind of Pd Zn bimetallic catalyst for preparing aryl cyanides
CN106243033A (en) * 2016-08-03 2016-12-21 凯莱英医药集团(天津)股份有限公司 The preparation method of aromatic nitrile compounds

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ANDREW L. COLB: ""Photochemical Cyanation of Acetophenones. Acetyl Displacement"", 《JOURNAL OF THE AMERICAN CHEMICAL SOCIETY》 *
ELISABETTA BRENNA,ET AL,.: ""Enantioselective Synthesis of (R)-2-Arylpropanenitriles Catalysed by Ene-Reductases in Aqueous Media and in Biphasic Ionic Liquid–Water Systems"", 《CHEMCATCHEM》 *
PENG YU ET AL,.: ""Nickel-Catalyzed Cyanation of Aryl Chlorides and Triflates Using Butyronitrile: Merging Retro-hydrocyanation with Cross-Coupling"", 《ANGEW. CHEM. INT》 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111187396A (en) * 2020-01-07 2020-05-22 复旦大学 Method for synthesizing linear polyacetylene substituted by different side groups through Heck coupling reaction
CN111187396B (en) * 2020-01-07 2022-05-20 复旦大学 Synthesis of Linear Polyacetylenes Substituted with Different Side Groups by Heck Coupling Reaction
CN116332794A (en) * 2021-12-24 2023-06-27 上海合全药物研发有限公司 Preparation method of aryl nitrile compound
CN115490613A (en) * 2022-09-05 2022-12-20 浙江工业大学 Preparation method of aromatic nitrile compound
CN115490613B (en) * 2022-09-05 2023-07-25 浙江工业大学 A kind of preparation method of aromatic nitrile compound
CN116354852A (en) * 2023-03-20 2023-06-30 南京理工大学 Strong pi electron delocalized alpha, beta-unsaturated nitrile and preparation method thereof

Also Published As

Publication number Publication date
CN110117237B (en) 2024-02-02

Similar Documents

Publication Publication Date Title
CN101952298B (en) Ligands for transition-metal-catalyzed cross-couplings, and methods of use thereof
CN110117237B (en) Preparation method of aromatic nitrile or alkenyl nitrile compound
CN108640869B (en) Transition metal catalyzed C-H coupling high-efficiency preparation of o-amidated aryl heterocyclic derivatives
CN108017479B (en) Manufacturing method of aromatic compound
CN108380245B (en) A bidentate phosphorus-azacarbene pair cymene-type ruthenium complex catalyst and its preparation method and synthetic application
CN108623495A (en) A kind of preparation method of aromatic nitriles or miscellaneous aromatic nitrile compounds
CN103254082A (en) Method for preparing chiral alpha-hydroxyl-beta-dicarbonyl compound by using air oxygen as oxidant
CN108658841B (en) Carbazole compound and preparation method thereof
CN113845550A (en) Flexible large-steric-hindrance N-heterocyclic carbene palladium complex containing halogenated benzene ring, and preparation method and application thereof
CN111187298B (en) A kind of C2-phosphonomethylene indole compound and its preparation method and use
CN111484436B (en) Method for introducing isopentene group into C3 position of indole
CN109369647B (en) A kind of synthetic method of fused ring [1,2-a]indole compound and 2,3-disubstituted indole compound
CN108299340B (en) Method for synthesizing 2-fluoro-N-substituted aryl acetamide compound
CN113200812B (en) 1,3,5-trisubstituted aryl compound synthesis method
CN111484437A (en) Method for introducing tertiary isopentenyl group to C3 position of indole
CN106946641A (en) A kind of method for preparing trans diphenylethlene class compound
CN112047925A (en) A kind of preparation method of N-(aryl/heteroaryl) alkyl-diamide
CN108440373B (en) Iron-catalyzed cyanoalkylindoline and preparation method thereof
CN106518761A (en) Preparation method of phenanthridine compound
CN113582797B (en) Method for synthesizing trifluoromethyl-1, 3-eneyne compound by copper catalysis
CN114349684B (en) Synthetic method of benzo [ c, d ] indole imine derivative
CN115232163B (en) Silicon center chiral molecular compound and preparation method and application thereof
Gan Monophosphine Ligands Bearing C− N Axial Chirality: Applications in Asymmetric Suzuki-Miyaura Cross-coupling Reactions
CN110272357A (en) A kind of preparation method of alkenyl cyanides
CN102086179A (en) Suzuki-Miyaura coupling reaction of iron catalysis iodide and bromide

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant